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CHAPTER 1 INTRODUCTION 
Study Overview  
 Chronic urogenital pain is an over-arching condition that encompasses disorders such as 
pelvic floor dysfunction, painful bladder syndrome, and interstitial cystitis; and primarily 
involves symptoms such as pain, pressure, and physical and sexual dysfunction. Chronic 
urogenital pain conditions are common, affecting nearly one in seven women in the United 
States. Further, $881.5 million is spent annually in health care costs for women with chronic 
urogenital pain, and the prevalence of chronic urogenital pain is expected to nearly double by 
2050 (Mathias, Kuppermann, Liberman, Lipzchutz, & Steege, 1996; Wu, Hundley, Fulton, & 
Myers, 2009). Women with these symptoms tend to have anxiety, depression, and relatively high 
rates of lifetime trauma and abuse. Indeed, almost half of such patients report abuse at some 
point in their lifetimes (Varma & Gupta, 2005), and many others have conflicts or stress from 
key relationships. There is theory and evidence suggesting that unresolved abuse or emotional 
conflicts can trigger or exacerbate urogenital pain and other symptoms (Abbass, Kisley, & 
Kroenke, 2009), but assessment of the presence and role of psychological stress is rarely done in 
women’s health care settings. Rather, medical assessment and treatment are focused on 
medication, physical therapy, and surgery. When mental health is assessed, it is typically done 
using brief scales of depression and anxiety, which do not provide a comprehensive view of 
stress, emotions, and health, nor do they motivate patients to change or relieve their symptoms.  
 There is little research on procedures for assessing stress, emotional processes, and their 
effect on physical symptoms in medical settings. However, cognitive and behavioral models 
propose behavioral assessment and motivational interviewing as ways to increase patient 
awareness and motivation to change (Goldfried, 1982; Flor & Turk, 2011; Prochaska, Redding, 
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& Evers, 2008; Rollnick, Miller, & Butler, 2008). Emotion-focused models, such as short-term 
psychodynamic therapy, affect phobia, and written emotional disclosure, emphasize the 
importance of increasing emotional arousal, focusing on unresolved conflicts, and experiencing 
and expressing avoided or suppressed emotions (Abbass et al., 2009; McCullough & Magill, 
2009; Frisina, Borod, & Lepore, 2004). Cumulatively, these literatures suggest that a 
comprehensive life-stress interview that focuses on increasing awareness of the links between 
stress, emotions, psychological conflicts, and physical health through use of experiential 
techniques might be the most effective way to increase awareness and motivation to change and 
reduce physical and psychological symptoms in women with chronic urogenital pain. In this 
dissertation, I examined the effects of an intensive life-stress interview compared to a wait-list 
control condition on measures of attitudes to a mind-body orientation as well as physical and 
mental symptoms. It is hypothesized that women in the life-stress interview condition would 
have improvements in awareness and motivation compared to those in the wait-list control 
condition, and that women in the life-stress interview condition would show more improvements 
in physical and psychological symptoms than those in the wait-list control condition.  
Background 
 Chronic urogenital pain can be broadly defined as pain lasting more than 6 months in the 
pelvic region and includes diagnoses such as pelvic floor dysfunction, chronic pelvic pain, and 
interstitial cystitis/painful bladder syndrome. These disorders often have multiple complex 
symptoms, are co-morbid with many other conditions, such as irritable bowel syndrome, 
fibromyalgia, and other chronic pain syndromes, and have unclear etiologies including multiple 
contributing factors. It is estimated that chronic pelvic pain affects approximately one in seven 
women in the United States: 3.3 to 7.9 million women suffer from interstitial cystitis or painful 
3	  
	  
bladder syndrome, and 28.1 million women have at least one pelvic floor disorder (Mathias et al., 
1996; Berry et al., 2011; Wu et al., 2009). Further, it is estimated that the number of women with 
a pelvic floor disorder will increase to 43.8 million by 2050 (Wu et al., 2009). Currently, $881.5 
million are spent annually in health care costs for women aged 18-50 years old that have chronic 
pelvic pain. These conditions also have a great impact on the daily functioning. Women with 
chronic pelvic pain reported that their ability to work effectively was diminished; 45% report 
decreased work productivity and 15% report losing pay from taking time off (Matthias et al., 
1996).  
In addition to the disability experienced from the physical symptoms associated with 
chronic urogenital pain conditions, these disorders are often related to psychological disorders, 
histories of trauma and/or abuse, and emotional neglect. One study estimated that 40-50% of 
women with chronic pelvic pain reported experiencing physical or sexual abuse in her lifetime, 
whereas population estimates in the U.S. suggest that approximately 25% of women experience 
physical or sexual abuse (Varma & Gupta, 2005). Additionally, when compared to women with 
chronic back pain as well as healthy controls, women with chronic pelvic pain were more likely 
to have experienced sexual abuse before the age of 15 and were more likely to have experienced 
physical abuse and emotional neglect than healthy controls (Lampe et al., 2000). A similar 
picture is seen in women with interstitial cystitis, for whom it has been estimated that 50% 
experienced some type of abuse. Of the women who reported experiencing abuse, many reported 
experiencing multiple forms of abuse, with 80% reporting emotional abuse, 65% reporting 
physical abuse, 58% reporting sexual abuse, 43% reporting domestic violence, and 17% 
reporting date rape (Peters, Carrico, Ibrahim, & Diokno, 2008). Currently, there are no data on 
the frequency of other, more nuanced psychological or internal conflicts in women with chronic 
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urogenital pain; however, our laboratory’s clinical work with women who have fibromyalgia, a 
conceptually similar pain condition, suggests that the vast majority of these patients had 
unresolved emotional conflicts, ranging from sexual and physical abuse to sibling rivalries and 
perceived pressure to be perfect from parents.  
Many women with chronic urogenital pain also experience psychological disorders and 
symptoms. Clemens, Brown, and Calhoun (2008) found that, compared to healthy controls, 
women with chronic urologic pain conditions were more likely to have various mental health 
problems: 14% met criteria for panic disorder, 11% had depressive symptoms, and 5% met 
criteria for major depressive disorder. At the multidisciplinary women’s urology center where 
this dissertation was conducted, we found that among 180 women with chronic urogenital pain, 
28% had elevated anxiety scores and 24% had elevated depression scores (Tomakowsky et al., 
2013). Overall, this suggests that chronic urogenital pain is not only physically painful and 
debilitating, but is made more complicated and distressing by histories of trauma, abuse, and 
psychological conflict, as well as difficulties with current depression and anxiety. However, 
typical treatment approaches for these conditions focus primarily on medication, physical 
therapy, or in some instances, surgery. These data suggest that assessment of mental health is 
indicated, although this does not occur regularly, and it is unclear how effective current 
assessments are at capturing mental health and its relationship to physical health.   
 In most cases, assessment of mental health is being done through brief self-report 
measures, which may be inaccurate or under-representative. Further, these kinds of measures do 
not often assess the source of the depression or anxiety, such as abuse history or more nuanced 
psychological problems, such as emotional or interpersonal conflict, which is particularly 
important for women with chronic urogenital pain. Howard (2003) has recommended a 
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comprehensive evaluation for women with chronic pelvic pain that can be extended to other 
chronic urogenital pain conditions, which includes a psychosocial history aimed specifically at 
depression, pain severity, and abuse history. However, Howard (2003) notes that it can be 
difficult to incorporate psychologists into medical clinics and the result is often that patients get 
referred to psychologists off-site, which substantially decreases the likelihood that they will 
follow through with the referral. This may occur for a variety of reasons, including the patient 
being unable to afford mental health care, reluctance to accept a referral out of fear or shame, or 
out of anger at the referring physician for implying that the patient is “crazy” or their symptoms 
are “all in their head.” Further, the assessment process described by Howard (2003) takes a 
biomedical approach, focusing on gathering information about the patient, but it does not provide 
the patient with any information or awareness of their health and takes a more authoritarian 
approach. Howard does not, however, provide any outcome data on the effectiveness of this 
interview technique. It is imperative that improved methods of assessing these important mental 
health factors (i.e., depression, anxiety, abuse history, and emotional and interpersonal conflict) 
be incorporated into the overall assessment of patient’s history in order to increase the patient’s 
awareness of the connection between their mental and physical health and to provide proper 
treatments, both physical and psychological. Although there is scarce literature on this topic, the 
theories and literature that do exist can provide guidance on how to best accomplish this task.  
Behavioral Theories   
Perhaps the most parsimonious way to create awareness is through the use of behavioral 
assessment. Goldfried (1982) describes the goal of behavioral assessment as assessing overt or 
objective behaviors directly and in the moment. This can be done through asking patients to 
identify the trigger or antecedent, environmental and internal factors, and consequences of the 
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behavior in question. Though this process originated from a behavioral perspective, it is widely 
used across many theoretical orientations and practices. More recently, Flor and Turk (2011) 
have indicated the importance of behavioral assessments for patients with chronic pain. 
Compared to the biomedical model most often implemented in primary care settings, a 
biopsychosocial model suggests assessment of psychophysiological, psychosocial, behavioral, 
and somatic factors related to illness, in addition to assessment of the physical symptoms (Flor & 
Turk, 2011). Additionally, behavioral assessments can serve as a way to motivate patients to see 
how they can change their pain (or health behavior) through tracking their symptoms and 
learning about the triggers and consequents to the pain, rather than relying on their physicians to 
tell them how to manage their pain (Flor & Turk, 2011). Often, for pain patients in general, and 
women with chronic urogenital pain in particular, this awareness and motivation can be 
enhanced through having the patient complete a series of diaries for which they are asked to 
track times they have pain or symptoms in conjunction with details about the intensity and 
duration of the pain, as well as what they were doing, thinking, and feeling before and after the 
pain. Flor and Turk suggest that by doing this, patients and their providers can have a continuous 
understanding of the patient’s symptoms, the triggers and consequences, and see how links and 
patterns develop over time, indicating that behavioral assessment can increase awareness of the 
mind-body link. A similar technique is frequently used in cognitive-behavioral therapy for 
patients with depression. These patients are asked to track their mood, thoughts, and behaviors 
over a series of days as a mechanism to build awareness of the pattern of their symptoms. 
Additionally, research shows that when patients are asked to simply track and log certain 
behaviors, such as food consumption, they begin to change their behavior, perhaps because they 
are becoming more aware of that behavior which may have previously been occurring 
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subconsciously or automatically (Kumanyika et al., 2009). Regardless of the method, the idea 
remains the same: when patients track their symptoms and the conditions surrounding those 
symptoms, a greater awareness of health can be cultivated, and this awareness may lead to 
behavior change and symptom improvement.  
Cognitive/Motivational Theories 
The Transtheoretical Model was created by Prochaska and colleagues as a way to explain 
differential success with psychotherapy that encompassed a variety of theoretical approaches and 
behavior changes. Prochaska and colleagues (2008) sought to empirically identify the processes 
through which successful behavior change occurs (e.g., consciousness raising, contingency 
management). Additionally, they identified six stages of change that describe the way in which 
behavior change occurs, often in a non-linear manner, over time. In the first stage, 
precontemplation, an individual does not believe they have a problem or behavior to change and 
has no intention of making changes. In the second stage, contemplation, the individual is 
planning on making changes but is still aware of the many cons to changing. In preparation, the 
third stage, the patient plans to make changes soon and has made a significant change toward a 
new behavior. In the action stage, the patient has begun making actual behavior changes. In the 
fifth stage, maintenance, the patient has sustained significant changes and is now focusing on 
preventing relapse to old behaviors. In the final stage, termination, the patient is no longer 
tempted by the old behavior and has complete confidence in their ability to sustain these changes. 
Prochaska also elaborates to describe these stages as occurring in a spiral pattern, with patients 
slipping back to former stages and progressing back up through later stages, rather than a linear 
pattern, in which patients master one stage and continue to the next, without any regression to 
former stages. In addition to the stages of change, Prochaska describes processes of change, or 
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the mechanisms through which changes can occur and at which stage these processes are likely 
to be effective. There are ten processes of change that have been supported by research, which 
are divided into cognitive or experiential processes and behavioral processes. The 
cognitive/experiential processes are best suited for patients in the early stages of change, whereas 
the behavioral processes are best suited for the later stages of change. Because it is likely that the 
majority of patients in the current study will be in the early stages of change (i.e., 
precontemplation and contemplation) regarding links between their stress, psychological 
conflicts, and health, this dissertation will focus on the cognitive/experiential processes.  
The cognitive/experiential processes involve: 1) consciousness raising, 2) dramatic relief, 
3) self-reevaluation, 4) environmental reevaluation, and 5) self-liberation. Of particular 
importance to this dissertation is consciousness raising, which is aimed at increasing awareness 
about the causes and implications of behaviors, and dramatic relief, which is aimed at increasing 
emotional experiences or responses. This theory suggests that matching client’s motivation or 
readiness to make changes to the processes of change can improve outcomes, and that it will be 
of particular importance to incorporate cognitive and experiential processes for patients in the 
early stages of change, such as women with chronic urogenital pain. Specifically, assessments 
should incorporate increasing awareness of the causes and effects of behavior, and focus on 
increasing emotional experiences.  
In a similar vein, motivational interviewing (MI) is a therapeutic approach created to 
enhance the motivation of patients who need to make behavior changes and is defined as “a 
collaborative, person-centered form of guiding to elicit and strengthen motivation for change” 
(Miller & Rose, 2009, p. 137). Miller and colleagues believe that most patients have a desire to 
change their maladaptive or unhealthy behavior, but many clinicians do not address patients in a 
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manner that allows the patient to change. Often clinicians place their own values for change onto 
the patient, instead of eliciting the patient’s values and goals. If patients can be approached 
through their own value system, motivation for change will be enhanced. The MI approach 
creates this environment for change through being collaborative, not authoritarian, which is what 
is most commonly seen in medical settings, enhancing and advocating for the patient’s ability 
and desire to create change, and allowing the patient to remain autonomous (Rollnick et al., 
2008). This approach suggests that when assessments are conducted in medical settings, 
clinicians, including physicians and mental health professionals, need to ask and understand what 
each individual patient’s motivation to change is and listen to them, rather than using a purely 
didactic approach. If patients with chronic urogenital pain can be empowered to use their 
resources, they will feel more like they have collaborated in their care, and therefore, more likely 
to be open to change. Indeed, this therapeutic technique has shown success in motivating 
behavior change for a variety of health behaviors, including substance abuse, problem drinking, 
tobacco use, and overeating (Rollnick et al., 2008). A meta-analysis indicated that MI led to 
significant improvements in 74% of the studies examined and had a moderate effect size 
compared to placebo treatment (Burke, Arkowitz, & Menchola, 2003).   	  
Emotion-Focused Theories  
In addition to behavioral, cognitive, and motivational theories, other approaches focus on 
exploring and activating emotion or affect as a mechanism to increase awareness about the 
dynamic relationship between psychological conflict, physiologic arousal, and physical 
symptoms. Wickramasekera (1988) proposed one such method to create awareness and a shift in 
beliefs about the link between physical and mental health. This method, he termed the Trojan 
Horse procedure, creatively uses an interview and physiological measurement to show the links 
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between thoughts, beliefs, and emotions on biologic/physiologic functions, links that 
Wickramasekera posits are critical in providing appropriate treatment for patients with somatic 
complaints. This link is created by interviewing patient about their lives, including their 
symptoms, emotions, and difficult life experiences or conflicts, while their physiologic responses, 
such as heart rate, blood pressure, temperature, and skin conductance, are monitored. The 
interviewer points out when there are shifts in physiologic reactivity and asks the patient what 
they believe is occurring, thereby allowing the patient to come to the realization that their 
biologic functioning is related to their thoughts and emotions on their own. The interview also 
allows the interviewer to help to shape the patient’s beliefs and ends with the interviewer giving 
the patient feedback about what the interviewer objectively observed during the session. 
Additionally, this procedure highlights the importance of including patients as collaborators in 
their health care, rather than as passive onlookers. Wickramasekera (1988) found that 83% of 
patients who went through this psychophysiological interview returned to continue 
psychotherapy, suggesting that the interview was effective in increasing awareness of a mind-
body link and motivating patients to change.   
Intensive short-term psychodynamic interviews have also been hypothesized as a way to 
increase emotional awareness and thereby decrease physical symptoms. This approach involves 
examining unconscious motivation, difficulty describing and expressing emotion, and broadly, 
making unconscious phenomena conscious by activating the underlying conflicts the individual 
is facing (Abbass et al., 2009). Abbass proposes that when emotions become too intense or 
conflicted for an individual, anxiety, as well as defenses against that anxiety, (e.g., suppression 
or avoidance of emotion) occur. Suppressing and avoiding emotions can lead to an exacerbation 
of physical symptoms, and ongoing avoidance serves to maintain those symptoms, which is a 
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common process in pain patients. Often, the suppression of emotions and process of somatization 
are unconscious to patients and, therefore, it is important to help patients develop a greater 
understanding and experiencing of their emotions. If women with chronic urogenital pain can 
experience their genuine emotions, somatization and physical symptoms can be decreased.  
Abbass (2009) suggests that this can be done through an emotion-focused diagnostic 
interview. This interview should actively explore emotions and the emotional reactions created 
from discussing emotionally challenging or difficult situations, particularly ones that have 
generated symptoms in the past. During the interview, the patient’s defenses should be 
acknowledged and discussed, and the interviewer should make attempts to disrupt the defenses. 
The interviewer should also monitor and manage the patient’s anxiety as needed through a 
cognitive approach, allowing the patient to intellectualize, until he or she is able to continue. 
Lastly, the interview should end with a summary of the findings and an indication of what the 
patient’s core conflicts are and how these are currently impacting their health.  
Overall, emotion-focused interviews and therapy have shown effectiveness in improving 
outcomes for patients for somatic disorders. Broadly, research indicates that short-term 
psychodynamic therapy, a form of emotion-focused intervention, is effective, efficacious, and 
reduces health-care utilization (Abbass, 2005; Abbass, 2003). One review examined seven 
studies that examined the cost-effectiveness of short-term psychodynamic therapy and found that 
in the majority of studies, patients who engaged in short-term-psychodynamic therapy, compared 
to treatment as usual or medication controls, had a significant decrease in utilization of physician 
and hospital services, medication use, and health care costs (Abbass, 2003). Averaging results 
from these studies indicated that $1,537 per patient per year would be saved. A meta-analysis 
examined 14 studies that used short-term psychodynamic therapy for somatic conditions (Abbass 
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et al., 2009). This meta-analysis revealed that 91% of studies found benefits of short-term 
psychodynamic therapy on primary health outcomes. Additionally, the majority of studies 
reported improvements on social-occupational functioning and reductions in psychological 
symptoms and health care utilization. Results from this meta-analysis found that short-term 
psychodynamic therapy had moderate effect sizes (d = 0.58-0.78 SD) compared to control 
groups in the short-term (less than 3 months). Additionally, the most powerful effects from short-
term psychodynamic therapies were found in studies that were emotion-focused compared to 
insight-focused. These findings are supported by a meta-analysis on the effects of short-term 
psychodynamic therapy on depression (Cuijpers, de Maat, Abbass, de Jonghe, & Dekker, 2010). 
This meta-analysis indicated that there was a large improvement (effect size = 1.34, 95% CI 1.13 
– 1.55) on depressive symptoms compared to controls, and that these benefits were maintained 
one year after treatment. In general, short-term psychodynamic therapy was comparable to other 
therapies, though in the short-term, other therapies showed more improvements; however, 
differences in improvement were not maintained at 3-month follow-up. Similarly, a randomized 
controlled trial was conducted on 211 patients with somatic pain disorders, comparing the effects 
of short-term interpersonal psychodynamic therapy to enhanced medical treatment (Sattel et al., 
2012). Results from this study indicated that at 9-month follow-up, physical quality of life and 
somatization improved; however, no significant differences were seen in depression, health 
anxiety, or health care utilization. Research suggests that using this therapy for patients with 
personality and Axis I disorders led to significant improvements on outcomes (McCullough & 
Magill, 2009). Lumley and colleagues (2008) conducted an emotional exposure pilot 
intervention for patients with fibromyalgia. This study found a moderate to large impact on stress 
symptoms, symptom impact, and emotional distress, and a small to moderate effect on pain and 
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disability at 3-month follow-up. These studies suggest that emotional exposure therapies can be 
effective in improving psychological and physical health.  
Similar to the short-term psychodynamic therapy, affect phobia therapy, created by 
McCullough and colleagues (2009), is another approach that highlights the role of affect and 
emotional conflict in psychological and physical symptoms. From this perspective, most if not 
all problems can be related back to conflicts individuals have with particular emotions, or a fear 
of a particular emotion. As with other fears or phobias, the suggested intervention is exposure 
and response prevention to the feared or avoided emotion. To do this, patients are encouraged to 
access their core, typically feared or avoided, emotion without using their defenses. This is 
facilitated by the therapist who is guiding the patient towards exposure and eventually expression 
of the core emotion, regulating inhibitory affects, and eventually helping the patient to have a 
restructured, healthier sense of themselves and others.  
Written emotional disclosure (WED) is another technique aimed at allowing patients to 
express, rather than suppress, their deepest, genuine emotions about trauma or conflicts without 
censorship. Pennebaker, who pioneered this technique, believed it would be effective in reducing 
physical symptoms based on the idea that when individuals suppress their emotions, they are 
more likely to develop somatic complaints, and that by using a technique that allows them 
expression of emotions, physical relief can occur. Generally, this technique is beneficial. Meta-
analyses indicate significant, albeit small (d = 0.19) improvements on physical and psychological 
well-being for patients (Frisina, Borod, & Lepore, 2004). Norman and colleagues (2004) 
examined the effects of WED in 48 women with chronic pelvic pain. Results from this study 
indicated that WED decreased pain severity at 2-month follow-up. Additionally, this study found 
that WED, compared to control writing, led to benefits in women who were elevated on 
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ambivalence over emotional expression, catastrophizing, or negative affectivity. These results 
suggest that expression of emotions and trauma is of particular importance for women with 
chronic urogenital pain, who are more likely to have emotionality and/or conflicts over 
emotional experience.  
Summary and Goals of Current Study 
Chronic urogenital pain is a common but debilitating set of conditions that has a 
significant impact on the health care system and leads to substantial suffering. Additionally, it is 
not uncommon for women with chronic urogenital pain to have experienced physical or sexual 
abuse, particularly in childhood, and to have current symptoms of depression and anxiety. In our 
clinical work with a conceptually similar patient population, we have discovered that a majority 
of patients with fibromyalgia report experiencing some form of psychological conflict, ranging 
from sexual abuse to parental pressure to be perfect, and we suspect this will be similar for 
women with chronic urogenital pain, though no such data yet exists on the frequency of more 
nuanced psychological conflict. There is a clear need to adequately address both the physical and 
psychological history of women with these conditions to ensure proper interventions, and to 
reduce the burden on the health care system. However, current evaluations in primary care and 
specialty centers most frequently involve self-report questionnaires of depression and anxiety, 
which do not assess important psychological conflicts. When medical or clinical interviews are 
conducted, they tend to be focused on gathering data from the patient, rarely focus on life stress, 
and often do not provide feedback for the patient of the patterns between their physical health 
and life stress.  Despite these shortcomings, an abundance of theories and research have pointed 
to the importance of increasing an awareness of the link between stress, psychological conflict, 
and physical symptoms. These theories suggest that this awareness might be most effectively 
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cultivated through use of emotion-focused experiential techniques. It is imperative that improved 
techniques for evaluating and assessing life history and its relationship to physical health be 
empirically examined for women with chronic urogenital pain.  
The goal of the current study was to test the efficacy of a novel life-stress interview for 
women with chronic urogenital pain in a multidisciplinary, tertiary care setting. The life-stress 
interview was aimed at increasing awareness of the link between stress, emotions, and physical 
symptoms through a collaborative, emotion-focused, and experiential evaluation of physical and 
psychological symptoms, stressors, and interpersonal conflicts. A secondary goal of the study 
was to improve health and functioning in patients who engaged in the enhanced life-stress 
interview.  
Women with chronic urogenital pain were recruited from the Women’s Urology Center at 
Beaumont Hospital. Participants reported on their pain, physical functioning, urogenital 
symptoms, psychological symptoms, attitudes, and motivation. After this initial evaluation, they 
were randomized to the life-stress interview immediately or to a wait-list control condition. The 
life-stress interview consisted of one, 90-minute session with a trained interviewer. Participants 
were asked to complete a follow-up evaluation 6 weeks after randomization. Participants in the 
wait-list control condition were offered the opportunity to engage in the life-stress interview after 
they completed their 6-week follow-up evaluation.   
Hypotheses 
 It was hypothesized that women in the life-stress interview group would demonstrate 
greater improvements in awareness and motivation than those in the wait-list control condition. 
Specifically, it was hypothesized that patients would increase their awareness of links between 
their mind and physical health, as demonstrated by an increase in attribution of their physical 
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condition to somatic causes, rather than to physical or environmental causes and an increase in 
stage of change. Additionally, it was hypothesized that women in the life-stress interview group 
will have greater improvements in physical health, psychological symptoms, and interpersonal 
functioning than those in the wait-list control condition. Specifically, it was expected that there 
would be improvements on pain severity, pain interference with functioning, pelvic floor 
dysfunction symptoms, depression, anxiety, interpersonal sensitivity, and maladaptive patterns of 
interpersonal functioning in women who engaged in the life-stress interview compared to the 
control condition at follow-up.  
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CHAPTER 2 METHODS 
Participants 
Participants were women with chronic urogenital pain conditions who were recruited 
from a multidisciplinary women’s urology center in metro Detroit. Participants had a primary 
urogenital pain (e.g., dyspareunia, vaginitis) disorder. These disorders are often characterized by 
chronic pain (lasting more than 6 months), pressure, and discomfort related to sexual, bladder, or 
gynecologic dysfunction, and are highly co-morbid with somatic disorders, such as irritable 
bowel syndrome, migraine headaches, and fibromyalgia. Though women with other solely 
urologic conditions (e.g., overactive bladder, incontinence) are treated at the women’s urology 
center, only patients with chronic urogenital pain conditions were sought for the current study. 
For a comprehensive list of disorders that were included, see Appendix A. Patients were also 
included if they were 18 to 80 years old. Patients were excluded if they: a) had a current 
psychotic disorder; b) were unable to communicate in English; c) were unable to read; d) were 
cognitively impaired or had dementia; or e) were been deemed too psychiatrically unstable by 
their clinician at the Women’s Urology Center to meaningfully complete this study. Participants 
were allowed to engage in the study regardless of current medication use and engagement in 
other treatment.   
Of the 106 patients who were screened for eligibility, only 85 remained eligible after 
screening, and all 85 consented to participate. However, only 73 patients completed the baseline 
measures, and 70 of these were randomized; the other three could not be contacted. Of the 70 
randomized participants, 45 participants (64.2%) were randomized to receive the life-stress 
interview, but 8 of them did not receive the interview: four were unable to be contacted to 
schedule their interview, three reported they no longer had time to participate, and one reported 
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that her health declined too much to participate. All 37 participants who engaged in the interview 
completed their follow-up measures, and the eight participants who were unable to schedule their 
interview did not complete follow-up measures. Thus, 37 participants completed the interview 
and follow-up measures, and constitute the interview group for analyses.  The eight participants 
randomized to this condition but who did not receive the interview were excluded from analyses, 
consistent with the approach used by Thorn et al. (2011). 
Further, 25 participants were randomized into the wait-list control group, and 21 of those 
completed follow-up measures; four control participants were unable to be contacted to complete 
their follow-up evaluation. Thus, a total sample of 62 participants received the assigned 
condition: 37 participants who completed their interview and the 25 control participants. This 
sample of 62 participants who completed the study per protocol (i.e., completed the intervention 
they were assigned) was the analyzed sample.  
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Figure 1. CONSORT Diagram 
 
 
These 62 participants had an average age of 45 years old, and the majority (58.9%) were 
married or in a committed relationship. Additionally, participants were primarily Caucasian and 
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were relatively highly educated. See Table 1 below for complete description of demographic 
information for the overall sample and each group.  
 
Table 1. Demographics and Medical Background by Whole Sample and Treatment Group 
 Whole Sample Interview Group Wait List Control 
Age  46.03 (15.10) 44.89 (15.34) 47.72 (14.88) 
Duration of physical 
symptoms (years) 
7.93 (9.66) 8.33 (10.29) 7.36 (8.83) 
Race    
Caucasian 87.1% 91.9% 80.0% 
African 
American 
8.1% 5.4% 12.0% 
Other 4.8% 2.7% 8.0% 
Education     
Less than 
HS 
1.6% 0.0% 4.0% 
HS or GED 11.3% 13.5% 8.0% 
Some 
college 
30.6% 35.1% 24.0% 
Bachelor’s 
degree 
29.0% 21.6% 40.0% 
Master’s 
degree 
24.2% 24.3% 24.0% 
Doctoral 
degree 
3.2% 5.4% 0.0% 
Relationship status    
Married or 
committed 
relationship 
58.1% 56.7% 60.0% 
Widowed 6.5% 8.1% 4.0% 
Divorced 16.1% 13.5% 20.0% 
Never 
married 
17.7% 21.6% 12.0% 
Currently in 
psychotherapy 
33.9% 32.4% 36.0% 
Previous experience 
in psychotherapy 
80.6% 73% 92.0% 
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Procedure 
Clinicians (i.e., physicians and nurse practitioners) at the urology center identified 
potential participants by the patient’s diagnosis during a routine visit to the clinic and notified the 
researchers of patients who had a qualifying diagnosis and who indicated that they were 
potentially interested in participating in a research study. Patients were then contacted 
immediately after their appointment with their clinician for a brief screening to determine 
eligibility. During this brief screening, potential participants were given an overview of the study 
and were screened for inclusion and exclusion criteria. If they remain interested and eligible, 
written informed consent was obtained, and a link to complete the baseline measures online was 
provided, which allowed participants to complete questionnaires at home at a time that was 
convenient for them. Paper versions of questionnaires, to be completed at home after their initial 
screening, were available for participants without access to a computer or Internet. Participants 
were instructed to complete their questionnaires as soon as possible after their screening and 
were informed that they could not continue with the study until these measures were completed 
and submitted to the research team either electronically or through the mail (stamped and 
addressed envelopes were provided to participants completing the measures on paper). Both the 
interviewer and participant were blinded to condition until baseline measures were completed.  
After the baseline health and psychological functioning measures were completed and 
submitted, participants were contacted via telephone to be randomized and to schedule their next 
appointment. To ensure that there was a large enough sample size in the life-stress interview 
condition for later secondary analyses of predictors and interview content, two-thirds of 
participants were randomized to receive the life-stress interview, and one-third of participants 
were randomized to the wait-list control condition. To control for interviewer effects, 
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randomization was stratified by interviewer. Those who were randomized to the life-stress 
interview returned to the women’s urology center for their 90-minute interview as soon as 
possible after completing baseline measures and were scheduled at that time to complete their 
follow-up. Participants in the wait-list control condition were scheduled to complete their follow-
up evaluation and were given the opportunity to receive the life-stress interview after completion 
of follow-up measures. Follow-up measures of health and psychological functioning were given 
6 weeks after randomization for both conditions. Participants were given $10 compensation for 
completion of each of the two evaluations (baseline and follow-up), were given $20 for 
completion of the interview, for a possible total of $40. After completion of the study, all 
participants were given a list of mental health referrals and recommendations.  
Life-Stress Interview  
The life-stress interview was a one-session interview lasting 90 minutes conducted by a 
trained interviewer (i.e., clinical psychology graduate students). All interviews were 
audiorecorded for supervision purposes and so the fidelity and content of the interviews could be 
analyzed at a later date. A licensed clinical psychologist supervised all interviews.  
The goal of the interview was to provide participants with a greater awareness of their 
physical and psychological health throughout their lives and the role that stress has played in 
their health. The interview consisted of two phases. The first phase involved obtaining a life 
history from the participants, which included a detailed examination of their health and 
symptoms, stressful life situations, and core conflicts. Participants were asked to describe any 
significant medical conditions they had experienced throughout their lives, including major 
illnesses, surgeries, and chronic diseases. They were also asked to describe all stressful or 
traumatic life experiences, including a general description of the nature of their childhood, 
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relationship with important people in their lives, including parents, siblings, and romantic 
partners. Participants were specifically asked if they had experienced specific traumatic 
experiences, including neglect, physical and/or sexual abuse. Lastly, participants described 
specific core conflicts they might have struggled with, such as being perfectionistic, feeling 
misunderstood, etc. Throughout this portion of the interview, links between physical health and 
stress were pointed out to the participant.  The second phase was an experiential component 
during which participants were assessed on their ability to express two important relational 
emotions or needs: 1) empowerment and 2) connection/caring. Participants were asked to 
demonstrate how to show strength and connection/caring through their tone of voice, posture, 
and language towards key people in their lives with whom they had a conflictual relationship, as 
identified in the initial phase of the interview. The interviewer coached participants to make their 
expression of these key relational emotions as complete and genuine as possible. For example, 
participants were often asked to increase the volume of their voice and to use stronger language 
and body postures.   
Throughout the interview, participants were asked to rate their physical symptoms on a 
scale of 0 (“no symptoms) to 10 (“severe symptoms”). At the end of the interview, participants 
were asked what they discovered about themselves in the interview, were given a summary of 
their strengths and weaknesses, and areas they may wish to continue to work on. They were also 
provided a handout describing the relationship between emotional suppression and health, and 
ways to express their emotions privately and within important relationships as a mechanism to 
improve their physical symptoms. See Appendix C for the handout provided to participants.  
Immediately before and after the interview, participants completed brief measures of 
mood and physical symptoms. Reactions to the interview were assessed immediately after the 
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interview was completed. Data collected from these measures (and immediately physical 
symptom ratings) were not analyzed for this dissertation. For the complete life-stress interview 
protocol refer to Appendix B.  
Wait-list Control  
Six weeks after participants were randomized into the wait-list control condition they 
completed follow-up measures. At this time, they were offered the opportunity to engage in the 
life-stress interview. Those who were interested received the interview shortly after completion 
of follow-up measures.  
Measures  
Attitudinal Outcomes 
General Attribution of Symptoms. This was measured using the Symptom Interpretation 
Questionnaire (SIQ; Robbins & Kirmayer, 1991). The SIQ consists of 14-item measuring the 
degree to which participants attribute their symptoms in three areas: psychological (“if I had a 
prolonged headache, I would probably think it was because, I am emotionally upset”), somatic 
(“if I had a prolonged headache, I would probably think it was because there is something wrong 
with my muscles, nerves or brain”), or normal/environmental (“if I had a prolonged headache, I 
would probably think it was because a loud noise, bright light or something else had irritated 
me”). At baseline this scale had adequate reliability for each subscale (Cronbach’s alpha 
psychological α = .88, somatic α = .71, normalizing α = .84). At follow-up this scale had 
adequate to good reliability for each subscale (psychological α = .91, somatic α = .74, 
normalizing α = .86). The SIQ yielded scores on three subscales corresponding to the three areas 
of attribution. All items were rated on a scale of 0 (not at all) to 3 (a great deal) and were 
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averaged to yield subscale scores. Higher scores on each subscale indicated higher levels of 
symptom attribution in that area.  
 Specific Symptom Attribution. This was assessed using a 2-item measure created 
specifically for this study. This scale (e.g., “If I have elevated symptoms related to my urogenital 
pain/gynecologic condition, I would think it was due to: a) my emotions, b) my biologic make-
up, c) something in my environment”) examined the degree to which patients attributed their 
specific urogenital pain symptoms to psychological, somatic, or biological factors. Patients 
provided scores for each of those three areas, ranging from 0 (not at all) to 3 (a great deal). Items 
were averaged on their respective subscale, with higher scores indicating a higher level of 
symptom attribution in that area. This scale had poor reliability for each subscale at baseline 
(psychological α = .55, somatic α = .55, normalizing α = .58) and at follow-up (psychological α 
= .66, somatic α = .71, normalizing α = .37). 
Stages of Change. This was assessed with an adapted version of the Change Assessment 
Questionnaire, which was reduced to 9 items for the current study to reduce patient burden 
(CAQ; McConnaughy, Prochaska, & Velicer, 1983). Items from this questionnaire align with the 
stages of change as proposed by Prochaska’s transtheoretical stage of change model. The CAQ 
yielded scores on 4 subscales: precontemplation (“The best thing I can do is find a doctor who 
can figure out how to get rid of my symptoms once and for all”), contemplation (“Even if my 
symptoms doesn’t go away, I am ready to start changing how I deal with it”), action (“I am 
testing out some stress management techniques to manage my symptoms better”), and 
maintenance (“I use what I have learned to help keep my symptoms under control”). Items were 
rated on a scale of 0 (strongly disagree) to 4 (strongly agree) and then averaged, with higher 
scores on each of the subscales indicate higher levels of that stage of change. In the current study, 
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the CAQ had poor reliability at baseline (precontemplation α = .41, contemplation α = .53, action 
α = .32) and reliability ranging from poor to acceptable at follow-up (precontemplation α = .48, 
contemplation α = .74, action α = 77).  
Symptom and Health Outcomes  
 Pain severity. Pain severity was assessed using the pain severity subscale of the Brief 
Pain Inventory (BPI; Cleeland & Ryan, 1994). The BPI-pain severity subscale consists of 4-
items measuring the degree of pain experienced by participants (“Please rate your pain by 
circling the one number that best describes your pain at its worst in the last week”). Items were 
rated on a scale of 0 (no pain) to 10 (pain as bad as you can imagine) and averaged, with higher 
scores indicating more pain. The BPI pain severity scale had good reliability at both baseline (α 
= .87) and follow-up (α = .90).  
Physical Dysfunction. Physical dysfunction was assessed using the physical dysfunction 
subscale of the BPI (Cleeland & Ryan, 1994). The BPI-physical dysfunction severity subscale is 
a 7-item subscale measuring the degree to which physical interference with functioning is 
experienced by participants (“Rate how much your pain has interfered with your mobility (ability 
to get around)”). Items were rated on a scale of 0 (does not interfere) to 10 (completely 
interferes), and averaged, with higher scores indicating worse physical functioning and more 
physical interference with functioning. For the current study, the physical interference with 
functioning subscale had good reliability at both baseline (α = .94) and follow-up (α = .94). 
Somatic Symptoms. This was measured using the 15-item Patient Health Questionnaire 
(PHQ-15; Kroeneke, Spitzer, & Williams, 2002). This questionnaire examined how much 
individuals are bothered by somatic symptoms (e.g., headaches, dizziness, shortness of breath) 
and rated on a scale of 0 (not bothered at all) to 2 (bothered a lot). Items were averaged to yield a 
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total score, in which higher scores indicated more somatic symptom distress. The PHQ-15 had 
good reliability (baseline α = .82, follow-up α = .80).  
Psychological Symptoms. This was assessed with the widely used Brief Symptom 
Inventory (BSI; Derogatis, 1993). The BSI consists of 53-items that measure a variety of 
psychological symptoms experienced over the past 7 days. To reduce patient burden and focus 
on constructs relevant to this population, only the depression, anxiety, and interpersonal 
sensitivity subscales were given, resulting in a shortened BSI that was 16 items. Each item was 
rated on a scale of 0 (not at all) to 4 (severely) and averaged, with higher scores indicating more 
psychological distress. At baseline, reliability was good for each subscale (depression α = .91, 
anxiety α = .85, interpersonal sensitivity α = .84) and total score (α = .94).  Similarly, at follow-
up, reliability was good for each subscale (depression α = .90, anxiety α = .81, interpersonal 
sensitivity α =.88) and total score (α = .94).   
Pelvic Floor Symptoms. This was measured using the Pelvic Floor Distress Inventory-
Short Form-20 (PFDI-SF-20; Ubersax, Wyman, Shumaker, McClish, Fantl, and the Continence 
Program for Women Research Group, 1995). The PFDI-SF-20 is a 20-item measure examining 
the degree to which pelvic floor disorder symptoms have been bothersome. All items were rated 
on a scale of 0 (not at all) to 3 (quite a bit) and yielded a total and 3 subscale scores: pelvic organ 
prolapse distress (“Do you experience heaviness or dullness in the lower abdomen?”), colo-
rectal-anal distress (“Do you feel you need to strain too hard to have a bowel movement?”), and 
urinary distress (“Do you usually experience urine leakage related to laughing, coughing, or 
sneezing?”). Items were totaled, and higher scores on each subscale and total score indicated 
more symptom distress. For the current study, reliability ranged from poor to good at baseline 
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(POPDI α = .64, CRADI α = .76, UDI α = .73, total α = .85). At follow-up, reliability ranged 
from fair to good (POPDI α = .73, CRADI α = .81, UDI α = .78, total α = .85).  
Global Health Improvement.  This was assessed with the Global Response 
Assessment (GRA), which is a 1-item measure examining symptom improvement and overall 
change in symptoms since the beginning of the study. This measure was completed at follow-up 
only. The item was rated on a scale of -3 (markedly worse) to +3 (markedly improved). Higher 
scores on this scale mean that symptoms have improved and negative scores on this scale 
indicate symptoms have worsened from the beginning of the study.  
Interpersonal Difficulties. This was measured using the Inventory of Interpersonal 
Problems-32 (IIP-32; Barkham, Hardy, & Startup, 1996). This questionnaire examined the 
difficulties that many people face in their relationships. The IIP-32 consists of 32 items rated on 
a scale of 0 (not at all) to 4 (extremely) and yields scores on 4 bipolar subscales that map onto 
the 4 basic interpersonal competencies identified by Gilbert (1989): 1) competition – hard to be 
assertive vs. too aggressive; 2) socializing – hard to be sociable vs. too open; 3) nurturance – 
hard to be supportive vs. too caring; 4) independence – hard to be involved vs. too dependent. 
Items are averaged on their respective subscale. Higher scores indicate more difficulty in that 
area of interpersonal functioning. In the present study, scales had reliability ranging from fair to 
good at baseline (dominance/control α = .78, vindictive/self-centered α = .91, cold/distant α = .87, 
socially inhibited α = .88, nonassertive α = .82, overly accommodating α = .70, self-sacrificing α 
= .78, intrusive/needy α = .80) and at follow-up (dominance/control α = .71, vindictive/self-
centered α = .87, cold/distant α = .77, socially inhibited α = .88, nonassertive α = .88, overly 
accommodating α = .78, self-sacrificing α = .83, intrusive/needy α = .79).  
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Satisfaction with Life. This was measured using the Satisfaction with Life Scale (SWLS; 
Diener, Emmons, Larsen, & Griffin, 1985). The SWLS is a 5-item measure of global life 
satisfaction (“The conditions of my life are excellent”). Items were rated using a 7-point scale 
and are rated from 1 (strongly disagree) to 7 (strongly agree) and were averaged to produce a 
total score, with higher scores indicating higher levels of global life satisfaction. In the present 
study, this scale had good reliability (α = .87) at baseline and at follow-up (α = .88).  
Statistical Analyses 
Data was entered in to SPSS version 22. All data was checked for accuracy and was 
examined for outlier variables and skewness. Though skewness was found on some variables, 
there was no differences in outcomes of analyses between transformed and original variables, 
thus only original values were used in analyses. To ensure randomization worked properly, 
demographics and baseline measures were compared between the two groups using t-tests. 
Analyses were conducted using the last value carried forward method for any data that was 
missing at follow-up.  
 To test the hypothesis that there would be differences between the life-stress interview 
group and the wait-list control group at 6-week follow-up, ANCOVAs, controlling for the 
baseline level of the outcome measure as well as baseline depression (discussed below), were 
conducted on each outcome measure. A significant group effect indicated significant mean 
differences after engaging in the interview between groups from baseline to follow-up. When a 
significant group effect was found, estimated marginal means were examined to understand the 
relationship. Paired-samples t-tests were also conducted to understand how changes occurred 
within each group. Additionally, effect sizes of both within and between conditions were 
conducted using Cohen’s d. For the within group analysis this was done using the following 
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calculation: (mean of follow-up – mean of baseline)/ pooled SD of change scores. For the 
between group analysis, effect size will be conducted with the following calculation: (mean 
change life-stress interview – mean change control group)/ pooled SD of change scores. Partial 
eta squared was also examined as an indicator of effect size after controlling for depression in the 
ANCOVA output. For Cohen’s d an effect size of 0.2 will be considered small, 0.5 will be 
considered moderate, and 0.8 will be considered large. For partial eta squared an effect size 
of .01 will be considered small, .06 will be considered moderate, and .14 will be considered large 
(Cohen, 1988).  
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CHAPTER 3 RESULTS 
Attrition analyses 
Participants who provided follow-up data (n=58) were compared to participants who did 
not provide follow-up data (n=4) on demographics and baseline measures to determine if 
differences existed between study completers and non-completers. Lower scores on 
precontemplation stage of change were observed in participants who did not provide follow-up 
data (M = 2.17, SD = 0.43) compared to participants who did provide follow-up data (M = 3.09, 
SD = 0.67; t(60)= -2.71, p =.05)). No other differences were observed on other baseline 
measures and demographic variables between participants who provided follow-up data and 
those who did not.  
Baseline differences between groups 
To test the success of randomization to create equivalent groups, baseline and 
demographic variables were examined between the immediate interview and wait list control 
(WLC) groups. There were no significant differences on demographic variables between groups.  
However, significantly higher levels of somatic symptoms (t(60) = -2.08, p = .04), pain 
interference with functioning (t(60) = -2.88, p = .006), depression (t(60) = -2.87, p = .006), 
interpersonal sensitivity (t(60) = -2.59, p = .01), and global psychological symptoms (t(60) = -
2.68, p = .01) were observed in the WLC group compared to immediate interview group and 
significantly lower precontemplation of change was observed in the WLC compared to the 
immediate interview group (t(60) = 2.20, p = .03).  
Higher baseline depression was positively correlated with higher baseline somatic 
symptoms (r = .32, p = .01), pain interference (r = .51, p < .001), interpersonal sensitivity (r 
= .75, p < .001), and global psychological symptoms (r = .91, p < .001); however, it was not 
significantly correlated with precontemplation of change (r = -.08, p = .52). Furthermore, 
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baseline depression had somewhat larger differences between conditions than the other variables 
noted here.  This suggests that the differences in various baseline measures between the two 
conditions might have been due to differences in depression.  Indeed, after controlling for 
baseline depression, the differences between the two conditions on the other variables were 
eliminated, with the exception of precontemplation of change, which remained significantly 
greater in the interview group.  Thus, baseline depression was controlled in subsequent analyses 
that compared conditions (in addition to the baseline level of the outcome measure), to adjust for 
this and other baseline differences between conditions.   
Acceptability of intervention 
Generally, this emotionally evocative intervention was well-received and valued by 
participants; 75% of participants who engaged in the interview reported learning new skills and 
69.5% reported an increased understanding of their medical problems as a result of the life-stress 
interview. Additionally, therapists perceived the vast majority of these patients as motivated to 
participate (91.9%). However, not all participants were able to fully engage in the experiential 
component or were able to fully access their difficult emotional experiences.  Therapists noted 
many participants had at least moderate difficulty expressing emotions (81%) and developing 
new insights (72.9%). 
Main effects 
Attitudinal outcomes 
Differences between participants who received the life-stress interview and those who 
were in the WLC condition were examined to test the hypothesis that participants who received 
the life-stress interview compared to the WLC condition would have greater improvements in 
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awareness in mind-body connection. Support for this hypothesis was limited. See Table 2 for 
complete ANCOVA main effects of attitudinal outcomes.  
On a measure of specific attribution of pelvic symptoms, there was a significant group 
difference on environmental attribution of symptoms at 6-week follow-up (F(1, 54)=4.54, p=.04), 
such that participants in the Interview group were significantly less likely to attribute their pelvic 
symptoms to environmental causes than the WLC group. Attribution of pelvic symptoms to 
environmental causes lowered non-significantly within the Interview group, but became slightly 
higher within the WLC group. No between group differences were observed on somatic 
attributions of pelvic symptoms (F(1, 55) = 1.11, p = .30), and both conditions lowered 
significantly in this attribution: Interview group, (t(34) = 2.28, p = .03) and WLC group (t(23) = 
3.39, p = .003). Further, there were no significant differences between groups on attribution of 
pelvic symptoms to psychological (F(1, 55) = 0.03, p = .86) causes and no significant within 
group effects.  
On a measure of general symptom attribution, no significant differences between the 
Interview and WLC group were observed on attribution of symptoms to somatic causes at 6-
week follow-up (F(1,57) = 2.52, p = .12); however, somatic attribution significantly lowered 
within the Interview group (t(35) = 2.22, p = .03), but there was no change within the WLC 
group (t(24) = 0.10, p = .92). No significant differences were observed on environmental causes 
on the general measure of symptom attribution between groups (F(1, 58) = 0.04, p =.85) or 
within groups from baseline to follow-up. Similarly, no significant differences were observed on 
psychological causes on the general measure of symptom attribution between groups (F(1,58) = 
0.37, p = .54) or within groups at follow-up.  
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Further, there were no significant group differences between Interview and WLC groups 
on stages of change, including precontemplation (F(1, 58) = 0.77, p = .39), contemplation (F(1, 
58) = 1.22, p = .27), action (F(1, 58) = 0.13, p = .72), and maintenance (F(1, 58) = 2.38, p = .12).  
However, as hypothesized, precontemplation lowered marginally within the Interview group 
from baseline to follow-up (t(36) = 1.87, p = .07). 
 
Table 2. ANCOVA Main Effects controlling for depression, Within and Between-Condition 
Comparisons of Attitudinal Outcomes from Baseline to 6-week Follow-up 
 
Interview Group 
(n = 37) 
Waitlist Control  
(n = 25) Group Effect 
 
 
M (SD) 
Adj M (SE) dwithin 
M (SD)   
Adj M (SE) dwithin F p dbetween 
Partial 
eta 
squared 
Specific SIQ 
Environmental 
        
Baseline  0.87 (0.79)  1.04 (0.86)      
Follow-up  0.65 (0.61) -0.27 1.06 (0.73) 0.04   -0.37  
Follow-up Adj 0.70 (0.10)  1.04 (0.12)  4.54 .04  .08 
Specific SIQ Somatic         
Baseline  0.97 (0.82)  1.31 (0.84)      
Follow-up  0.66 (0.79) -0.38* 0.78 (0.82) -0.74**   0.31  
Follow-up Adj 0.80 (0.11)  0.60 (0.14)  1.11 .30  .02 
Specific SIQ 
Psychological 
        
Baseline  0.90 (0.77)  1.04 (0.78)      
Follow-up  0.96 (0.80) 0.08 1.08(0.70) 0.05   0.08  
Follow-up Adj 0.99 (0.12)  1.02 (0.14)  0.03 .86  .001 
SIQ Somatic         
Baseline  0.85 (0.52)  0.93 (0.33)      
Follow-up  0.65 (0.38) -0.39* 0.92 (0.46) -0.02   -0.39  
Follow-up Adj 0.70 (0.07)  0.87 (0.08)  2.52 .12  .04 
SIQ Environmental         
Baseline  1.36 (0.54)  1.46 (0.56)      
Follow-up  1.23 (0.52) -0.26 1.38 (0.65) -0.14   -0.15  
Follow-up Adj  1.30 (0.08)  1.28 (0.09)  0.04 .85  .001 
SIQ Psychological         
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Baseline  1.14 (0.65)  1.18 (0.58)      
Follow-up  1.06 (0.61) -0.18 1.25 (0.67) 0.16   -0.41  
Follow-up Adj 1.10 (0.07)  1.17 (0.09)  0.37 .54  .01 
CAQ Pre-contemplation         
Baseline 3.18 (0.60)  2.80 (0.76)      
Follow-up  3.00 (0.67) -0.31† 2.88 (0.69) 0.14   -0.53  
Follow-up Adj 2.90 (0.09)  3.03 (0.11)  0.77 .39  .01 
CAQ Contemplation         
Baseline 3.68 (0.74)  3.91 (0.60)      
Follow-up  3.59 (0.92) -0.18 4.01 (0.68) 0.16   -0.37  
Follow-up Adj 3.87 (0.10)  3.87 (0.13)  1.22  .27  .02 
CAQ Action         
Baseline  3.76 (0.79)  4.12 (0.56)      
Follow-up  3.95 (0.79) 0.23 4.24 (0.82) 0.16   0.06  
Follow-up Adj 4.03 (0.12)  4.11 (0.15)  0.13 .72  .002 
CAQ Maintenance          
Baseline  4.05 (0.52)  4.12 (0.83)      
Follow-up  4.03 (0.80) -0.03 4.36 (0.76) 0.27   -0.31  
Follow-up Adj 4.03 (0.13)  4.36 (0.16)  2.38 .13  .04 
d-within is the within-condition effect size ((follow-up M – baseline M) / SD of the pooled 
change scores)). 
d-between is the between-condition effect size ((Interview follow-up M – baseline M) – (control 
follow-up M – baseline M)) / SD of the pooled change scores. 
* p < .05, ** p < .01,  *** p < .001  
 
 Symptom and health outcomes 
 Generally, improvements in physical symptoms, but not psychological or interpersonal 
symptoms, were observed in the life-stress interview group compared to WLC. See Table 3 for 
complete ANCOVA main effects of symptom and health outcomes.  
In general, significant differences on physical symptoms were found on the Interview 
group compared to WLC group at 6-week follow-up. Specifically, pain severity was significantly 
lower in the Interview group compared to the WLC group at follow-up (F(1, 58) = 4.52, p = .04). 
Within the Interview group, pain severity was marginally lower at follow-up (t(36) = 1.81, p 
= .08), whereas the WLC group showed higher, though non-significantly, pain severity (t(24) = -
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1.34, p = .19).  No significant differences were found between groups on BPI pain interference 
with functioning (F(1,58) = 1.02, p = .62), nor were there significant within-group changes.   
Significant group differences were observed on pelvic floor dysfunction symptom 
distress at follow-up. Specifically, overall pelvic floor symptom distress became significantly 
lower (F(1, 57) = 5.51, p = .02) in the Interview group compared to WLC group at 6-week 
follow-up. Overall pelvic floor symptom distress significantly lowered within the Interview 
group, (t(36) = 2.93, p = .006) compared to a very small, non-significant lessening in the WLC 
group, (t(23) = 0.60, p = .56). Significantly less colo-rectal-anal symptom distress (F(1, 57) = 
7.04, p = .01) were observed in the Interview group compared to WLC group at follow-up. 
Specifically, less colo-rectal-anal symptom distress was observed within the Interview group 
(t(36) = 2.27 p =.03), but did not change in the WLC group (t(23) = -0.37, p = .71). Further, 
marginally less pelvic-organ prolapse symptom distress (F(1, 57) = 3.69, p = .06,) were observed 
in the Interview group compared to WLC group at follow-up. Specifically, marginally less pelvic 
organ prolapse symptom distress was observed within the Interview group (t(36) = 1.90, p = .07) 
and no changes were observed within the WLC group (t(23) = -0.26, p = .80). No significant 
group differences were observed on urologic symptom distress (F(1, 57) = 1.35, p = .25); 
however, marginally less urologic symptom distress was observed within the Interview group 
(t(36) = 1.99, p = .06) and slightly lessened within the WLC group, though not significantly 
(t( 23) = 1.48, p =.15). No significant differences were found between or within groups on the 
PHQ-15, a measure of, somatic symptoms (F(1, 58) = 1.96, p = .17), or between groups on the 
global assessment of change ratings (F(1, 41) = 0.02, p = .89) at follow-up.  
Further, on measures of psychological functioning, there were no significant group 
differences on depression (F(1, 59) = 0.20, p = .66). In fact, the trend was opposite of that 
37	  
	  
hypothesized. Symptoms of depression lessened marginally within the WLC group at follow-up 
(t(24) = 1.80, p = .09), but did not change within the Interview group (t(36) = -0.26, p = .79). 
There were no significant differences between or within groups on anxiety (F(1, 58) = 0.30, p 
= .59), interpersonal sensitivity (F(1, 58) = 0.16, p = .69), or global psychological distress (F(1, 
58) = 0.01, p = .91). Further, there were no significant differences between or within groups on 
satisfaction with life (F(1, 57) = 1.47, p = .23). 
Significant differences between groups were observed on some measures of interpersonal 
functioning. Interpersonal dominance/control was marginally higher in the Interview group 
compared to WLC group at follow-up (F(1, 56) = 2.84, p = .097). Specifically, within the WLC 
group marginally less interpersonal dominance/control was observed (t(1, 36) = 1.99, p = .06), 
whereas there was a slightly higher, though non-significant, degree of this interpersonal style 
within the Interview group. Interpersonal vindictive/self-centeredness was moderately lower in 
the Interview group compared to WLC group at follow-up (F(1, 56) = 3.56, p = .06). Specifically, 
vindictive/self-centeredness was marginally lower within the Interview group (t(36) = 1.88, p 
= .07), but did not change within the WLC group (t(23) = 0.08, p = .94). Significant differences 
were not observed between groups on interpersonal social inhibition; however, there was 
significantly lower social inhibition within the Interview group (t(36) = 2.52, p = .02) and no 
change within the WLC condition. (t(23) = 0.32, p = .75). No other significant differences 
between or within groups were observed on additional measures of interpersonal functioning 
between groups at follow-up.  
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Table 3. ANCOVA Main Effects controlling for depression, Within and Between-Condition 
Comparisons of Symptom and Health Outcomes from Baseline to 6-week Follow-up 	  
 
Interview Group 
(n = 37) 
Waitlist Control  
(n = 25) 
Group Effect  
 
M (SD)   
Adj M (SE) dwithin 
M (SD)   
Adj M (SE) dwithin F p dbetween 
Partial 
eta 
squared 
Pain Severity         
Baseline  3.87 (2.03)  4. 24 (1.65)      
Follow-up 3.30 (2.24) -0.29† 4.51 (1.61) 0.15   -0.56  
Follow-up Adj 3.42 (0.26)  4.33 (0.32)  4.52 .04  .07 
Pain Interference with 
Functioning 
        
Baseline  3.85 (2.47)  5.92 (3.19)      
Follow-up  3.31 (2.50) -0.26 4.84 (2.72) -0.45   0.08  
Follow-up Adj 3.81 (0.34)  4.01 (0.42)  1.02 .62  .004 
PFDI-20 Total          
Baseline  78.29 (47.31)  110.96 (50.01)      
Follow-up  61.27 (44.95) -0.33** 104.71 (55.74) -0.10   -0.92  
Follow-up Adj 70.35 (5.63)  92.89 (7.22)  5.51 .02  .09 
PFDI-20 CRADI         
Baseline  19.78 (17.85)  26.86 (20.80)      
Follow-up  14.44 (16.56) -0.31* 26.93 (23.95) 0.00   -0.44  
Follow-up Adj 15.69 (2.34)  26.07 (2.95)  7.04 .01  .11 
PFDI-20 POPDI         
Baseline  23.96 (18.57)  37.29 (19.78)      
Follow-up  19.37 (16.32) -0.26† 36.31 (23.58) -0.05   -0.33  
Follow-up Adj 24.02 (2.27)  31.37 (2.87)  3.69 .06  .06 
PFDI-20 UDI         
Baseline  34.55 (23.72)  46.81 (21.57)      
Follow-up  27.46 (24.19) -0.33† 46.81 (22.18) -0.20   -0.13  
Follow-up Adj 30.22 (3.27)  36.60 (4.14)  1.35 .25  .02 
Somatic Symptoms          
Baseline  0.66 (0.44)  0.88 (0.35)      
Follow-up 0.58 (0.33) -0.23 0.82 (0.34) -0.28   -0.10  
Follow-up Adj 0.63 (0.04)  0.73 (0.05)  1.96 .03  .03 
Global Response Attribution         
Follow-up  4.83 (1.23) n/a 4.71 (1.33) n/a     
Follow-up Adj 4.81 (0.23)  4.75 (.34)  .02 .89  .000 
BSI Depression         
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Baseline  0.61 (0.76)  1.27 (1.05)      
Follow-up  0.64 (0.73) 0.04 1.04 (1.03) -0.36†   0.51  
Follow-up Adj 0.83 (0.10)  0.75 (0.12)  0.20 .66  .003 
BSI Anxiety         
Baseline  0.79 (0.77)  1.18(0.87)      
Follow-up  0.72 (0.67) -0.15 1.05 (0.87) -0.20   0.11  
Follow-up Adj .82 (.09)  0.90 (0.11)  0.30 .59  .01 
BSI Interpersonal Sensitivity         
Baseline  0.65 (0.78)  1.26 (1.07)      
Follow-up  0.66 (0.88) 0.02 1.09 (1.01) -0.24   0.32  
Follow-up Adj 0.86 (0.10)  0.80 (0.13)  0.16 .69  .003 
BSI Global Symptoms          
Baseline  0.69 (0.71)  1.23 (0.89)      
Follow-up  0.67 (0.68) -0.04 1.06 (0.84) -0.33   0.40  
Follow-up Adj 0.83 (0.08)  0.82 (0.10)  0.01 .91  .000 
Satisfaction with Life         
Baseline  4.40 (1.44)  3.65 (1.50)      
Follow-up  4.53 (1.52) 0.18 3.59 (1.39) -0.07   0.10  
Follow-up Adj 4.25 (0.13)  3.99 (0.16)  1.47 .23  .03 
IIP-32 Dominance/Control         
Baseline  1.83 (2.35)  3.13 (3.13)      
Follow-up  2.02 (2.32) 0.16 2.24 (2.71) -0.43†   0.61  
Follow-up Adj 2.46 (0.25)  1.77 (0.31)  2.84 .10  .05 
IIP-32 Vindictive/Self-
centered 
        
Baseline  2.16 (3.18)  3.50 (5.12)      
Follow-up  1.16 (1.42) -0.31† 3.28 (4.90)  -0.04   0.00  
Follow-up Adj 1.44 (0.51)  3.01 (0.63)  3.56 .06  .06 
IIP-32 Socially Inhibited         
Baseline  4.51 (4.43)  5.21 (4.43)      
Follow-up  3.41 (3.60) -0.41* 5.12 (4.92) -0.02   -0.19  
Follow-up Adj 3.80 (0.51)  4.31 (0.65)  0.36 .55  .01 
IIP-32 Cold/Distant         
Baseline 2.51 (3.36)  3.96 (4.52)      
Follow-up  1.89 (2.2.39) -0.20 3.24 (3.67) -0.18   0.13  
Follow-up Adj 2.21 (0.43)  2.88 (0.54)  0.88 .35  .02 
IIP-32 Overly 
Accommodating 
        
Baseline  6.16 (3.70)  6.13 (3.85)      
Follow-up  6.14 (4.65) -0.01 6.00 (3.73) -0.04   0.07  
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Follow-up Adj 6.32 (0.52)  5.63 (0.65)  0.66 .42  .01 
IIP-32 Self-sacrificing         
Baseline  7.58 (4.00)  8.00 (4.40)      
Follow-up  7.19 (4.38) -0.15 8.04  (4.42) 0.02   -0.16  
Follow-up Adj 7.50 (0.43)  7.83 (0.54)  0.22 .64  .004 
IIP-32 Intrusive/Needy         
Baseline  4.41 (3.89)  5.00 (3.98)      
Follow-up  3.76 (3.29) -0.22 3.88 (3.50) -0.43†   0.27  
Follow-up Adj 4.00 (0.41)  3.54 (0.51)  0.46 .50  .01 
IIP-32 Nonassertive         
Baseline  6.03 (4.00)  4.79 (4.08)      
Follow-up  5.27 (4.09) -0.25 5.56 (4.80) 0.14   -0.37  
Follow-up Adj 5.43 (0.61)  5.17 (0.78)  0.07 .80  .001 
d-within is the within-condition effect size ((follow-up M – baseline M) / SD of the pooled 
change scores)). 
d-between is the between-condition effect size ((Interview follow-up M – baseline M) – (control 
follow-up M – baseline M)) / SD of the pooled change scores. 
* p < .05, ** p < .01,  *** p < .001  
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CHAPTER 4 DISCUSSION 
Chronic urogenital pain conditions are a common set of disorders that frequently involve 
physical dysfunction and pain as well as higher occurrences of anxiety, depression, emotional 
conflicts, trauma, and abuse. Current medical assessment of these patients typically does not 
evaluate these highly co-morbid psychological problems, and when they do, they are typically 
done using brief self-reported measures of depression and anxiety. The current assessment 
practice largely ignores the important role of trauma, stress, and emotions in health, nor does it 
provide patients feedback for change. Thus, the goal of the current study was to examine the 
effects of an intensive, emotion-focused, life-stress interview compared to a wait-list control 
condition on improving motivation to change and awareness about mind-body connections and 
to improve physical health, psychological symptoms, and interpersonal functioning. Findings 
from the current study suggest that a one-session, intensive, emotion-focused life-stress 
interview can improve pain and pelvic floor symptom distress at 6-week follow-up. Limited, but 
potential support was found for improvements in interpersonal functioning as a result of the life-
stress interview; however, the interview had no effect on psychological symptoms, mind-body 
awareness, and motivation to change.  
Physical health outcomes  
Results for the hypothesis that participants who engaged in the life-stress interview would 
show greater improvements in physical health symptoms than participants in the control group 
was, generally, supported. Participants who engaged in the life-stress interview had less pain and 
pelvic floor symptom distress compared to the control group at follow-up. However, engaging in 
the life-stress interview had no effect on physical functioning or general health improvement.  
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The findings that pain severity and pelvic floor symptoms improved in the Interview 
group compared to the control group is consistent with the findings from a meta-analysis 
conducted by Abbass and colleagues (2009), which found that the majority of short-term 
psychodynamic therapy interventions, which included a minimum of five sessions, for patients 
with somatic illnesses, improved health outcomes. Similar results were also found in an 
uncontrolled trial of an emotional awareness and expression therapy for patients with chronic 
pain, which found a decrease in pain and pain interference with functioning after a consultation 
and 4 sessions of group therapy (Burger et al., 2016). The current study found similar effects to 
these studies, but, impressively, in a shorter period of time, suggesting that improvements in 
physical symptoms can be achieved using a brief, one-session emotion-focused interview and 
that longer-term interventions for patients with chronic urogenital pain are not necessarily 
required. Currently, cognitive-behavioral therapies are held as the “gold standard” treatment and 
are often viewed as the only evidence-based treatment available for patients with medically 
unexplained illnesses; however, results from the current study, in conjunction with support from 
previous research, indicate that emotion-focused and experientially-based assessment and 
interventions may be of equal importance, particularly for patients with chronic urogenital pain 
and other chronic pain or medically unexplained illnesses. Further, within the current medical 
climate there are increasing demands on behavioral health providers to create improvements for 
patients within a relatively brief period of time, and patients with medically unexplained medical 
conditions, such as chronic urogenital pain, are notoriously difficult to treat often create 
increased frustration for both patients and medical providers. Implementation of a relatively brief, 
one-session intensive interview that both provides information to inform treatment and gives 
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patients immediate skills for improvements as a standard protocol could prove to be invaluable 
within medical settings.  
It is also important to understand possible underlying mechanisms of change in the life-
stress interview. Findings from the current study are consistent with Sarno’s (1998) theory on 
somatization or TMS (which he calls, “tension myositis syndrome”). This theory suggests that 
“unexpressed rage” manifests itself as physical symptoms, and serve as an avoidance or 
distraction from the rage. Sarno suggests that to alleviate the physical symptoms, the individual 
needs to acknowledge and gain insight into the role of rage and its roots in possible childhood 
trauma or other emotional conflicts. Similarly, Davanloo, in his development of intensive short-
term psychodynamic therapy, proposed that “resistant” patients often have unconscious 
emotional experiences that need to be unblocked, allowing them to consciously experience 
difficult emotions. Through the process of unblocking these emotions, he witnessed an 
improvement in the most difficult of his cases; this was substantiated empirically with in studies 
showing improvements for patients in psychological and physical health after engaging in 
intensive short-term psychodynamic therapy (Abbass, Town, & Driessen, 2013). Both of these 
theories propose that a major mechanism of change is making unconscious or subconscious 
processes conscious (Abbass, Kisely, & Kroenke, 2009), which was also one of the primary 
goals of the current life-stress interview. Throughout each part of the interview, the patient was 
challenged to acknowledge emotional experiences and their links to health that they had not 
previously considered. This was done by gently pointing out links between stress and health 
during the first part of the interview and more directly challenging patients to activate and 
express emotional experiences, even when that was difficult for the patient, during the second 
part of the interview. This is perhaps best illustrated in a case example: a 42-year old woman 
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with 7 year history of pelvic floor dysfunction and a 15+ year history of migraine and irritable 
bowel syndrome (IBS) described growing up in a home with an alcoholic father who was 
emotionally abusive and a mother who spent most of her time trying to control her husband’s 
drinking, which resulted in neglecting the emotional needs of the patient and her siblings. As a 
result of growing up in this environment, the patient reported that she was eager to please others 
and to move out of her house as soon as she could; thus, she got married when she was 19 years 
old. Her husband was emotionally abusive and became sexually abusive toward her over time. 
Further, this patient had significant depression and a suicide attempt 3 years prior to participation 
in the current study. During her life-stress interview, she expressed that she had not previously 
made the links between her difficult childhood and her health, but thought that it explained a 
great deal about her. She also shared for the first time in her life that her husband was sexually 
abusing her and, though it was difficult to do, found significant relief in expressing both her love 
and care towards him and her significant, and appropriate, anger over the abuse. After engaging 
in the life-stress interview, the patient shared with her physical therapist at the Women’s Urology 
Center that this new way of thinking and accessing her emotions was life changing for her, 
creating a significant impact in her life more than any other prior therapy experience had been 
able to provide. This is an ideal example of how this interview can work and captures the spirit 
of the interview; when we can help patients to gain insight and express emotions in a novel way 
we can have a powerful impact on their physical health.  
In addition to the psychodynamic mechanisms at play in the life-stress interview, 
attachment theory can provide further understanding of how the interview might improve 
physical health, particularly because of the high frequency of difficult and traumatic childhoods 
experienced by our participants. Attachment theory proposes that early childhood experiences 
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with caregivers become internalized and impact how individuals interact in future relationships. 
Individuals can be categorized into four main attachment styles: secure, resulting in being 
comfortable depending on and being cared for by others, and comfort with independence; 
dismissive, resulting in becoming overly reliant on one’s self rather than others; preoccupied, 
resulting in being dependent on others for emotional support; and fearful, resulting in approach-
avoidance in relationships (Ciechanowski, Walker, Katon, & Russo, 2002). Attachment style is 
related to numerous aspects of functioning, including somatization and health care utilization 
(Ciechanowski et al., 2002). Specifically, Ciechanowski and colleagues (2002) found that within 
a women’s primary care clinic, patients with fearful or preoccupied attachment styles reported 
more physical symptoms than patients with a secure attachment style, and patients who had a 
preoccupied attachment style had the highest level of health care utilization. Not surprisingly, 
insecure attachment styles (i.e., dismissive, preoccupied, or fearful) and childhood trauma are 
related to increased somatization, particularly in women (Waldinger, Schulz, Barsky, & Ahern, 
2006). Although attachment style was not directly measured in the current study, the high levels 
of trauma, neglect, and emotional conflict from childhood that the majority of our patients 
reported suggest that it is likely that many of them have an insecure attachment style. Our life-
stress interview allowed patients to gain insight and understanding into the impact of their 
childhood stressors on their current health and psychological functioning. Further, many of our 
patients chose to use the experiential exercise in the second part of the interview to address an 
emotional conflict they were still harboring toward one of their parents. For example, one 
woman shared that she grew up in a home where she was explicitly told to not show her 
emotions, particularly anger, and that while she knew her parents loved her, they rarely 
expressed that to her. Her parents were also very religious, causing the patient to be reluctant to 
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share many of her experiences with her parents for fear of being judged. In her twenties, the 
patient had an abortion that she still felt conflicted over nearly a decade afterward and which she 
was never able to tell anyone in her family. As a result, her adult relationships were characterized 
by defensiveness and a fear of intimacy. Through the experiential exercise, the patient identified 
a part of her that was grieving for the loss of child she aborted, but also that this loss was still 
unresolved because she felt such conflict about how her parents would view her if they knew her 
secret. After expressing her core emotions about wanting to be loved unconditionally by her 
parents, the patient was able to more fully grieve her loss and begin the process of forgiving 
herself. It is likely that if the interview had focused only on her abortion and not the attachment 
issues, she would not have felt as much relief. This process of addressing and beginning to 
resolve issues from childhood, often for the first time, may have provided our patients with a 
corrective experience related to attachment that ultimately allowed for the resolution of physical 
symptoms.  
Interpersonal functioning  
In general, engaging in the life-stress interview had only minimal impact on interpersonal 
functioning. Interpersonal domineering/control slightly increased in the interview group and 
decreased in the control group. Conversely, interpersonal vindictive/self-centeredness decreased 
in the interview group and did not change in the control group. Similarly, interpersonal social 
inhibition decreased within the interview group and did not change in the control group. 
Higher scores on interpersonal domineering/control on the IIP-32 suggest a difficulty 
with a self-held belief that one is too controlling or manipulative and has difficulty with relaxing 
control within relationships (Barkham, Hardy, & Startup, 1996). Interestingly, individuals in the 
interview group had slight increases on their self-report of domineering/control, whereas 
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individuals in the control group saw decreases in these tendencies. One possible explanation is 
that the life-stress interview encouraged individuals to be assertive and powerful where needed 
in their important relationships, thereby encouraging participants to take a more active, or 
controlling, stance in their relationships, rather than a passive engagement. The interview may 
have provided a buffering effect against becoming passively engaged in relationships, which 
may have contributed to the improvements in physical health observed within the Interview 
group.  
Interpersonal vindictive/self-centeredness was also significantly different between groups, 
but in contrast to the previous finding, vindictive/self-centeredness marginally decreased within 
the Interview group and did not change with the control group. Higher scores on vindictive/self-
centeredness on the IIP-32 suggest that patients are quick to express anger and irritability, are 
highly focused on revenge, frequently fight with others, and generally express and experience 
anger in a way that is maladaptive within relationships (Barkham et al., 1996). Thus, decreases 
on vindictive/self-centeredness as a result of the life-stress interview might indicate that the 
intervention was effective in helping participants to express their anger within interpersonal 
relationships in a healthy, balanced way, rather than in explosive or inappropriate ways. This is 
consistent with what participants would often report – that they tended to suppress their anger 
until they found themselves having inappropriate outbursts towards important people in their 
lives, thereby reinforcing the idea that anger is an unsafe emotion to express. One of the goals of 
interview was to teach participants to express, rather than suppress, important emotions, 
especially anger, toward the correct person (e.g., toward a loved one, rather than a stranger) in a 
more balanced, healthy manner, which typically involved balancing multiple emotional 
experiences. For example, we would often coach patients to express both their love/care and 
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anger/assertiveness within their relationships, rather than just focusing on the expression of anger, 
which was often the patient’s default mode. It appears that the life-stress interview was at least 
somewhat effective in helping individuals reach this goal.  
Additionally, a significant decrease in social inhibition was observed within the Interview 
group, though this was not significantly different from the control group. Higher scores on social 
inhibition suggest that the patient has difficulty with feeling anxious or embarrassed around 
others (Barkham, Hardy, & Startup, 1996). Thus, decreases in social inhibition within the 
Interview group might indicate that as a result of learning healthy, genuine emotional expression 
participants began feeling more comfortable and relaxed within their interpersonal relationships.  
Taken together, it appears that engaging in the life-stress interview allowed patients to 
become more powerful, while also providing them with skills to express their anger in healthy, 
balanced ways, allowing them to feel more relaxed and comfortable within their important 
relationships. This is a promising finding because it provides confirmatory evidence that the life-
stress interview works in the manner proposed: increasing genuine emotional expression leads to 
improvements in interpersonal functioning.  
Interestingly, the life-stress interview did not appear to impact other important areas of 
interpersonal functioning, such as a lack of assertiveness and being overly accommodating that 
are often observed within women with chronic urogenital pain conditions. It might be the case 
that some of these interpersonal styles are more ingrained, similar to the chronic nature of 
psychological conflicts and disorders seen in these patients, making it more difficult for a brief 
intervention to create change within a short period of time.  
Psychological health outcomes 
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In contrast to the findings on physical health symptoms and interpersonal functioning, 
engaging in the life-stress interview did not affect psychological symptoms, including global 
psychological symptoms, depression, anxiety, and interpersonal sensitivity compared to those in 
the control group. Surprisingly, opposite to my hypothesis, symptoms of depression improved 
within the control condition, whereas no changes in depression were observed within the 
interview group.  
Although previous research has shown that emotion-focused interventions can be 
effective in improving psychological health for patients with medically unexplained illnesses 
(Abbass et al., 2009; Burger et al., 2016), the current study did not support this hypothesis. In 
contrast to the hypothesis, a meta-analysis on the effects of written emotional disclosure in 
patients with medical or psychiatric disorders showed that this emotion-focused intervention lead 
to improvements physical health outcomes, but only a small, non-significant effect on 
psychological outcomes, congruent with the current study (Frisina et al., 2004). This suggests 
that is unclear if and how emotional disclosure-type interviews can improve psychological health. 
It is possible that psychological disorders, particularly within women with chronic urogenital 
pain conditions, are more chronic and long-standing than their physical complaints, thus making 
these symptoms harder to shift. This may have been more evident within the Women’s Urology 
Center where this study was conducted, which typically sees patients who have more significant 
medical and psychological histories. This follows the proposed mechanism of change in somatic 
illnesses, which suggest that the course of these physical illnesses begins with difficult 
psychological experiences (e.g., trauma, interpersonal conflict, neglect) that then manifest as or 
exacerbate physical symptoms (Sarno, 1998). If this is the case, it might be more likely that the 
newer symptom (i.e., pain or physical dysfunction) will be more likely to improve first, whereas 
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the more chronic and deeply rooted symptom (i.e., psychological symptoms, emotional conflict) 
might take longer to improve.  
Further, it is possible that an emotionally evocative intervention, such as our life-stress 
interview, initially causes an increase in emotional stress, which may need a longer follow-up 
time period to improve. This was reflected in the lack of change in anxiety, depression, 
interpersonal sensitivity, and global psychological symptom symptoms within the Interview 
group compared to the improvement in depressive symptoms observed over time in the control 
group. Similar results have been found in studies of written emotional disclosure. Gillis and 
colleagues (2006) examined the effects of written emotional disclosure with patients with 
fibromyalgia and found that immediate increases in negative affect were observed after the 
intervention, but were not maintained long-term. Likewise, in a small study of written emotional 
disclosure for trauma survivors, higher negative affectivity was observed five weeks after 
disclosure compared to a control group (Gidron, Peri, Connolly, & Shalev, 1996).  
Attitudinal outcomes 
Support for the hypothesis that participants in the Interview group would increase their 
awareness of links between stress, trauma, and physical health was limited. The only significant 
difference found between groups was on environmental attribution of symptoms. Specifically, 
participants in the Interview group were less likely to attribute their pelvic symptoms to 
environmental (e.g., a loud noise, bright light) causes than participants in the control group. It is 
somewhat unclear why only environmental attribution of pelvic symptoms changed. One 
possible explanation is that during the first part of the life-stress interview, links between 
physical health and stressors or significant life experiences were highlighted to help individuals 
see potential mind-body links. Thus, is it possible that as a result of engaging in the interview 
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individuals became more aware that their physical symptoms were due to other causes, such as 
stress or difficult emotional experience, than external events or environmental cues. Further, the 
life-stress interview often primarily focused on pelvic symptoms rather than general physical 
health, resulting in patients changing their attributions of only their pelvic symptoms. 
However, symptom attributions remained largely unchanged as a result of the life-stress 
interview. The Symptom Interpretation Questionnaire that was used to capture symptom 
attribution might be tapping into a stable, trait-like style of symptom attribution, rather than a 
changeable construct. Indeed, no studies were found in which symptom attribution as measured 
by the SIQ was changed as the result of an experiment or intervention. This suggests that this 
measure may not be sensitive to change, and was not appropriate to use in this study.  
Additionally, the hypothesis that readiness to change mind-body views of health would 
change in the Interview group compared to the control group was not supported. No differences 
were found between groups on stage of change, and only a slight decrease in precontemplation 
was observed within the Interview group, suggesting that engaging in the life-stress interview 
was slightly effective in increasing motivation to change awareness regarding links between 
stress and health. It should be noted that in the current study the measure used to assess stages of 
change (CAQ) had poor reliability. Due to this poor reliability, any possible predictive validity of 
this measure is constrained, which may have contributed to the lack of findings. However, one 
possible explanation for the relative lack of findings is that change occurs in this intervention 
through a different mechanism than previously hypothesized (i.e., increase in awareness of mind-
body connections will result in health and symptom improvement). It is possible that participants 
needed to experience an actual change in their behavior and symptoms before being willing to 
shift their views on the nature of their physical symptoms from medical to having a 
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psychological or stress component; perhaps a longer follow-up time period would have revealed 
a shift in attributions of physical symptoms.  
Clinical observations 
It is important to highlight some of the unique characteristics of women with chronic 
urogenital pain, particularly those who are treated in a tertiary care clinic, that were observed 
during this study, as well as some of the distinctive factors of the tertiary care clinic where this 
study was conducted, which likely influenced outcomes of the current study. First, in 
interviewing 37 women with chronic urogenital pain, we learned a great deal about the emotional 
conflicts and difficulties these women face. Certainly many of these women experienced a 
traumatic event, including sexual and physical abuse and neglect, but what was perhaps more 
unexpected was the level of perfectionism experienced by these women and extreme degree to 
which this personality style impacted their health and relationships. A common story heard from 
our patients was not one of abuse, as is often expected in women with urogenital pain conditions, 
but rather one of feeling neglected or not cared for as a child, leading to a sense of needing to do 
everything perfectly, which as adults most frequently showed up as a need to be the perfect 
spouse, mother, and/or employee, often as the expense of one’s health. Relief was often found 
after helping participants to identify where their perfectionistic style began, how it impacted their 
health, validation of the benefits of this style, and helping participants to express the important 
emotions they frequently neglected in favor of being “perfect.” This realization within the 
current study aligns with Sarno’s (1998) proposition that in addition to trauma, certain 
personality styles, including perfectionism, are the result of suppressed rage, which often 
manifests as somatic physical complaints. It is not surprising, then, that women who have this 
personality style would find benefit from an emotion-focused, life-stress interview.  
53	  
	  
Further, tertiary care clinics, such as the Women’s Urology Center, typically see patients 
with complex medical and psychosocial backgrounds and with conditions that cannot be well-
managed with their primary care physicians. Compared to patients in a primary care clinic, these 
patients tend to have more significant and complex histories of trauma, abuse, and neglect, 
making it much more difficult to create change both psychologically and physically. In fact, only 
one or two patients in the study did not report at least one significant traumatic event or 
emotional conflict, and most of the stories participants shared began during childhood, making 
the impact of these traumas more ingrained. The degree of trauma, emotional conflict, and 
psychological disorders creates an additional challenge in treating these patients, which may also 
explain the somewhat limited findings in the current study, particularly the lack of improvement 
in psychological symptoms, mind-body awareness, and, to a lesser extent, interpersonal 
functioning.  Greater improvements from a life-stress interview might be achieved in a different 
medical setting with less complex patients, such as within a primary care clinic, and this should 
be tested in future research.  
There were also factors unique to the Women’s Urology Clinic that likely impacted 
findings for the current study. The Women’s Urology Center is a multidisciplinary clinic that 
provides patients with a wide array of care, from medical care to psychotherapy, physical therapy, 
massage, and reiki. Further, these patients are encouraged to engage in other forms of 
complementary medicine offered outside of the center, providing a holistic treatment approach. 
Though these women have higher severity of symptoms and psychosocial difficulties, they are 
given wonderful support and treatment, which likely helps them to improve more swiftly. In fact, 
the Women’s Urology Center is one of the only medical settings in Metro Detroit that has 
physical therapists specifically trained in pelvic floor physical therapy and frequently has women 
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travelling across the state and country to receive services. Additionally, all patients at the 
Women’s Urology Center engage in an in-depth assessment during their first appointment at the 
clinic during which their medical and psychological trauma histories are assessed. As a result of 
this wonderful, cutting-edge treatment approach, the women who participated in the current 
study were receiving many treatments, had already been exposed to the idea that their physical 
symptoms may be related to their stress and trauma, and had been given opportunities to disclose 
their psychological stress and trauma history in a supportive environment. Indeed, many of the 
women in study were either currently in psychotherapy or had been in psychotherapy in the past. 
Combined, these ongoing psychological processes may have minimized the effects of the life-
stress interview in the current study.  
It is also important to note that beyond the improvement in health outcomes observed in 
the current study, the life-stress interview was well received by both patients and medical 
providers. Patients who engaged in the interview frequently acknowledged that although 
addressing their trauma history and emotional conflicts was difficult, it was important work that 
was often not addressed at all or not addressed fully in previous therapy experiences. Often 
medical providers, psychologists, and patients tend to shy away from emotion or trauma-focused 
interventions for fear of opening “Pandora’s Box” and not having the resources to fully address 
the issues at hand. Although this is an important phenomenon to consider, we found that patients 
were much more resilient in addressing their emotional difficulties than is often feared. In the 
current study, only one patient expressed a negative view of the brevity of the interview to the 
research team during her life-stress interview, whereas the vast majority of participants reported 
finding the interview helpful. During the life-stress interview this participant disclosed a 
complicated sexual abuse history that was directly related to her current physical health and her 
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relationship with her husband, which she had previously not shared with anyone in her life. She 
reported after the interview that discussing this was incredibly important to her health, but she 
was experiencing an increase in distress and wanted more follow-up to further address these 
issues (we provided this patient with resources to find a therapist and scheduled to see the 
Women’s Urology Clinic’s psychologist until she could establish care elsewhere). Generally, 
patients reported that they valued the opportunity to view their physical health in the context of 
their psychological and emotional difficulties, often citing appreciation for being viewed as a 
whole person rather than just an individual with a complex medical problem. 
There was also great support for this study from the medical providers at the Women’s 
Urology Center, suggesting that this type of interview is not only effective but feasible in this 
type of setting. The medical providers who aided in recruitment in the current study often 
expressed the great need that they saw for their patients for interventions that focused on their 
patient’s emotional experience. Medical providers are quite limited in the time they can spend 
with their patients, averaging less than 10 minutes per patient, and often struggle with how to 
best help their patients that they know have psychosocial needs in addition to their medical 
complaints. Providing a standard life-stress interview could begin to lessen the burden from 
medical providers, while also providing them a more comprehensive view of their patient. 
Limitations 
Although the current study found promising results on the effectiveness of a novel, life-
stress interview for women with chronic urogenital pain conditions, there are limitations to this 
study that should be noted. First, the life-stress interview was compared to a no-interview control 
group, thus the findings suggest that engaging in this novel intervention is better than no 
intervention at all; however, the current study cannot determine whether anything specific about 
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this interview led to the outcomes, rather than non-specific factors such as meeting with an 
interested interviewer.  It will be necessary to compare the life-stress interview and more active 
control conditions or even alternative skills-based approaches to determine whether the stress 
and emotion focus of the current interview is responsible for the outcomes. Second, this study 
examined only women with chronic urogenital pain conditions, so the results may not be 
generalizable to other medical conditions. It is possible that patients with similar medically 
unexplained illnesses (e.g., fibromyalgia, irritable bowel syndrome, migraine headaches) could 
benefit from the life-stress interview, and future studies should examine this possibility. Further, 
patients with other medical conditions that do not tend to be co-morbid with trauma and/or 
emotional conflict (e.g., cancer) may not benefit as much from the life-stress interview. 
Attrition is another important limitation of the current study. Of the 45 participants who 
were randomized into the interview group, eight participants were unable to complete the life-
stress interview. The participants who were unable to engage in the life-stress interview reported 
that difficulty with scheduling and problems with their health prevented them from completing 
the interview, which reflects the complexity of the lives and health of women with chronic 
urogenital pain, as well as the perceived value of the interview and the emphasis on the voluntary 
nature of the study. As a result of these difficulties with attrition, only 62 participants could be 
analyzed, which was less than the 90 needed for adequate power according to power analyses. 
This impacted our statistical power and ability to find potential significant differences between 
groups. Furthermore, follow-up data was missing for some participants. Missing data in this 
study was replaced using a last value carried forward technique, which is only a rough estimate 
of participant’s scores. 
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Further, this study found that participants who had lower scores on the precontemplation 
stage of change were less likely to engage in and complete the study. This suggests that patients 
who already acknowledged the importance of addressing their emotional stress related to their 
physical health are less likely to find an emotion-focused intervention useful. Patients who are in 
precontemplation and contemplation stages of change are more likely to benefit from 
interventions that increase their insight, and this life-stress interview might be more appropriate 
for these patients, whereas patients further along in stage of change might benefit more from, and 
be more interested in, interventions aimed at providing them specific tools or skills for change 
(Prochaska, Redding, & Evers, 2008). Despite randomly assigning participants to interview 
groups, participants in the control group had greater symptoms of depression at baseline than 
those in the interview group. As a result, depression was statistically controlled in analyses. 
Additionally, the current study showed poor reliability on the CAQ, a measure of stage of 
change, suggesting that we may not have been able to correctly capture stage of change. 
Similarly, the SIQ, which was used to measure symptom attribution to environmental, 
psychological, or somatic causes, did not show differences between conditions or changes over 
time in either condition. Perhaps this measure should not have been selected for inclusion in this 
study, as it more likely measures trait-symptom attributions, rather than state-symptom 
attributions and, therefore, is not likely to change as the result of an intervention. Indeed, there is 
no “gold standard” measure of awareness of mind-body connections or motivation to improve 
awareness of links between stress and health, and the difficulty in capturing these construct by 
current measures may reflect the lack of findings on these outcomes. As we continue to see the 
effectiveness and efficiency of emotion-focused interventions for patients who have difficult and 
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complex medical conditions, it will become important to develop measures that accurately reflect 
these important constructs.  
Future Directions 
The current study is a promising start into the relatively unchartered territory of 
examining the effectiveness of directly targeting trauma, emotional conflict, and relational 
problems with patients in a medical setting as a means to create health improvements; yet, there 
is room to grow this body of research. First, future studies should seek to have a larger sample 
size than the current study to ensure adequate statistical power for detecting meaningful group 
differences and to ensure that findings are reliable. Future studies should also seek to examine 
whether emotion-focused interviews can improve outcomes above that of cognitive-behavioral, 
or other skills-based, interviews. Including longer follow-up time periods in these studies will 
also clarify how long gains are maintained from the life-stress interview and whether 
improvements in psychological symptoms and changes in mind-body awareness occur over time, 
particularly because these might take longer to improve.  
It will also be important for future research to examine which patients benefit from the 
life-stress interview based on important background factors and characteristics. It might be the 
case that patients who are more newly diagnosed might benefit more from the life-stress 
interview than patients who have had a chronic urogenital pain condition for a longer time. It 
will also be interesting to determine if there are particular patient populations that would benefit 
the most from the life-stress interview by comparing the effects of the interview in other 
medically unexplained conditions, such as irritable bowel syndrome, migraine headaches, and 
fibromyalgia. It is also possible that factors such as stage of change, attachment style, and ability 
to tackle difficult emotional experiences can predict which patients are more likely to improve 
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from the life-stress interview. For example, patients in early stages of change (i.e., 
precontemplation and contemplation) might benefit more from an insight-building interview than 
patients further along in stage of change (i.e., preparation, action, maintenance). Further, patients 
who have an insecure attachment style might also have greater benefit from the life-stress 
interview than patients who have a secure attachment style. Additionally, patients with a greater 
ability and willingness to engage in emotion-focused experience exercises are more likely to 
have greater improvements from the life-stress interview.  
  As we continue to develop this life-stress interview it will be important to develop ways 
to assist patients in accessing difficult emotional experiences. The life-stress interview was 
difficult to engage in for some individuals, and it might be important to alter the interview for 
these patients. For example, using mindfulness exercises that focus on difficult emotional 
experiences and eliciting patient’s values surrounding emotional expression within their 
relationships might allow patients to gain easier access to their difficult emotional experiences 
and increase willingness to engage in experiential exercises. The life-stress interview might also 
benefit from incorporating motivational interviewing in the beginning phase of the interview to 
increase motivation to change view on the relationship between stress and physical health.  
Further, efforts should be made to disseminate and implement this evidence-based 
assessment into clinical practice, a challenge faced by many evidence-based assessments and 
treatments. Research needs to work not only toward creating assessments that are effective, 
understanding how and for which patients they work, but also toward providing greater access to 
these assessments. Currently, there is no universal strategy to disseminate evidence-based 
assessments and treatments, but examination of successful dissemination programs recommends 
conducting needs and barriers assessments, formal training and education of mental health 
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providers, and assessing sustainability of the new protocol (McHugh & Barlow, 2010). These 
strategies should be used to begin to disseminate the life-stress interview. Particularly for this 
interview, it will also be critical to educate medical providers, who are most frequently providing 
education and recommendations to their patients, about the usefulness of this interview.  
Implications  
The findings from this study indicate that brief, even one-session assessment and 
interventions that are experiential and emotion-focused can be effective in improving pain, 
physical symptoms, and, to a lesser extent, interpersonal functioning for women with chronic 
urogenital pain conditions. These findings are incredibly promising, considering the current lack 
of psychosocial assessments conducted on patients with chronic urogenital pain, the relatively 
ineffective psychological interventions available to these patients, and the burden that these 
conditions place on the health care system, patients, and their providers. Conditions such as 
chronic urogenital pain are very common, yet are hard to diagnose and treat, and patients with 
these conditions often spend many months, even years, seeking a proper diagnosis, which often 
takes examinations from multiple medical providers, including primary care physicians, 
gynecologists, and urologists. Participants in the current study often expressed frustration that 
their medical symptoms were not well understood by their providers and often felt that they were 
being told that their symptoms were “all in their head,” yet clinical work with these patients and 
ample research indicates that women with chronic urogenital pain are more likely to have 
experienced a traumatic event, abuse, emotional conflict, and psychological distress. It is critical 
that that our current medical system adapt to the needs of these patients. It is possible that one 
way to do this is to begin to implement our life-stress interview as standard protocol for every 
patient in a primary care or tertiary care clinic where these patients are being treated. This type of 
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assessment can provide in-depth information to the medical and behavioral health team at these 
medical clinics, which may serve to guide their treatments, and, as we have seen in the current 
study, can begin to provide patients some relief from their pain, physical dysfunction, and 
difficulty in interpersonal situations.  
In sum, patients and medical providers found this brief interview helpful, as supported by 
improvements in pain, physical symptoms, and interpersonal functioning, and achievable in a 
one-session visit in a tertiary care clinic, suggesting that emotion-focused interventions for 
patients with complex and often medically unexplained symptoms can be effective and efficient. 
This calls for a shift in thinking about how medical and psychological providers address these 
patient’s physical and psychological complaints. We no longer need to rely solely on cognitive-
behavioral symptom management techniques, but can incorporate brief, emotion-focused 
interventions.   	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APPENDIX A. DIAGNOSES INCLUDED IN STUDY 
 
  Urogenital 
Pain   
  Mononeuritis of Limb 
  Dyspareunia 
  Vaginismus 
  Vulvodynia, unspecified 
  Vulvar vestibulitis 
  Other vulvodynia 
  Myalgia/myositis unspecified 
  Neuralgia, neuritis, radiculitis unspecified 
  Abdominal pain, unspecified 
  Abdominal pain, generalized 
Gynecologic   
  Vaginitis vulvovagintis unspecified 
  Ulceration of vulva unspecified 
  Cystocele, midline 
  Rectocele 
  Uterine Prolapse without Vaginal Wall prolapse 
  Pelvic muscle wasting 
  Other specified genital prolapse 
  Other specified symptoms of female genital organs 
  Unspecified symptoms of female genital organs 
  Symptomatic menopause 
  Atrophic Vaginitis, postmenopause 
  Muscular wasting/atrophy not classified 
  Spasm of muscle 
63	  
	  
APPENDIX	  B.	  INTERVIEW	  PROTOCOL	  	  
1. Have patients complete “Before Session Ratings” 
2. Discuss ground rules for sessions (5 min) 
 
a. There are many things to cover each session, and I will keep you on track 
b. Remind the participant about confidentiality & audio recording (for supervision 
purposes) 
c. Remind them that session will run for 90mins, verify ability to participate 
 
3. Introduction (5 min) 
 
a. Rationale  
• Remind them that they’re here because they reported symptoms during their 
intake (this won’t apply for Jen); our role is helping you understand the 
potential role of stress on your health; want to see what role, if any, stress 
plays in your health 
b. Meta-communication 
i. We are going to go through a variety of questions about your life, 
including questions about your health and stressful life experiences; some 
of these might be difficult to share and some that might not be. You don't 
know me well, or how I might respond, but I encourage you to be honest 
and open with me. I know that remembering when a symptom started and 
how regularly it occurred can be difficult to remember, so please just try 
your best to give the most accurate response you can.  
 
 
 
4. Health History (10 mins) 
 
Goal:	  Get	  an	  overview	  of	  the	  participant’s	  health	  history,	  including	  the	  onset	  and	  development	  of	  symptoms	  and/or	  medical	  conditions	  	  	  
• Let’s start by doing a brief overview of your health history (have a sheet of 
paper to fill out) 
• From birth – now (with approximate ages) 
 
a. Create a timeline with patient 
i. Health issues/symptoms  
Tell me about what kinds of health problems you’ve had in your life, 
starting in childhood until now. 
• Go over checklist of things they might have missed 
o Abdominal pains 
o IBS 
o Headaches (tension, migraine) 
o Unexplained rashes 
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o Insomnia or trouble sleeping 
o Fibromyalgia 
o Chronic pain 
o Pelvic pain 
o PMS 
o Fatigue  
o TMJ 
	  
5. Stress History (30 minutes) 
Goal: to help the patient develop an awareness that their physical symptoms are linked to 
their stress/emotions 	  
Stressful life experiences, including mental health issues (anxiety/dep):  
 
Introduce the task: I want you to go through their life, from birth to now, telling me any 
stressful events or difficult experiences that you have had  
 
Meta-communication about comfort of sharing:  
I	  know	  that	  many	  of	  these	  questions	  can	  be	  difficult	  to	  share	  and	  they	  might	  be	  
questions	  that	  you	  are	  not	  normally	  comfortable	  sharing	  with	  other	  people	  in	  your	  life.	  
It	  is	  normal	  to	  feel	  somewhat	  uncomfortable	  sharing	  information	  about	  really	  difficult	  
experiences	  in	  your	  life.	  	  
	  
{How	  are	  you	  feeling	  about	  sharing	  with	  me	  today?}	  
	  
{What	  are	  your	  concerns	  about	  sharing	  with	  me	  today?}	  
	  
{I	  can	  understand	  if	  you	  feel	  reluctant	  to	  tell	  me	  some	  things,	  but	  I	  really	  encourage	  
you	  to	  give	  it	  a	  try,	  even	  if	  it	  is	  difficult	  or	  embarrassing	  or	  upsetting.}	  
 
 
After they share, go through the checklist for issues they may have forgotten: 
 
I	  want	  you	  to	  know	  that	  many	  people	  have	  gone	  through	  these	  experiences.	  I	  will	  ask	  
you	  about	  some	  specific	  events	  and	  situations	  that	  we	  know	  are	  not	  uncommon	  
experiences	  for	  people	  and	  we	  want	  to	  know	  better	  what	  your	  experience	  with	  these	  
situations	  is.	  	  
 
• Checklist: have you ever experienced any of the following: 
o Serious disaster (war, explosion, earthquake) 
o Childhood maltreatment (neglect, not fed or clothed, foster care) 
o Violence between family members (e.g., hitting, kicking, slapping, 
punching)?  
o Divorce (self or parents) 
o Emotionally abused or neglected (shamed, embarrassed, ignored, or 
repeatedly told that you were “no good”)? 
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o Abortion or miscarriage  
o Private health issues –STDs 
o Has a baby or child of yours ever had a severe physical or mental 
handicap? 
o Care-giving for someone close to you who had a severe physical or 
mental handicap 
o Abused or physically attacked (not sexually) by someone you 
knew? Someone you didn’t know? 
o Harassed by sexual remarks, jokes, or demands for sexual favors  
o Touched or made to touch someone else in a sexual way because 
he/she forced you in some way 
o Have sex (oral, anal, genital) when you didn’t want to because 
someone forced you in some way 
o Have any of the events mentioned above ever happened to someone 
close to you so that even though you didn’t experience it yourself, 
you were seriously upset by it? 
o Has someone close to you died (expectedly or unexpectedly)? 
• Secrets? Conflicts or private struggles with things? 	  
I	  would	  like	  you	  to	  share	  something	  you	  never	  shared	  before	  or	  haven’t	  shared	  
with	  me,	  maybe	  something	  private	  like	  a	  secret.	  You	  don't	  know	  me	  well,	  or	  
how	  I	  might	  respond,	  but	  I	  encourage	  you	  to	  be	  honest	  and	  open	  with	  me.	  I	  can	  
understand	  if	  you	  feel	  reluctant	  to	  share	  that	  with	  me,	  but	  I	  really	  encourage	  
you	  to	  give	  it	  a	  try,	  even	  if	  it	  is	  difficult	  or	  embarrassing	  or	  upsetting.	  
 
	  
i. Identifying core conflicts using the checklist   
• Ask generally, what do you struggle with or have a hard time 
expressing? What do you generally avoid? What do you feel pressured 
to do or say? What are you conflicted over? 
After they share, go over examples from the list.  
• Checklist: 
Private Conflicts:  
 
o Conflicts or struggles over sexual behaviors, identity or 
relationships 
o Not fitting in or feeling ostracized (being teased or picked on, 
being shy and reserved, not being athletic or popular) 
o Feeling inferior to siblings or other relatives (not as beautiful, 
funny, athletic, interesting, accomplished) 
o Resentment and/or anger towards family members, religious 
leaders, neighbors 
 
Psychological Consequences: 
o Feeling pressure to succeed or be perfect 
o Disappointing people 
o Getting too close to people 
o People, memories, or things that you avoid? 
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o Loss and abandonment (losing a parents or child, divorce) 
o Never feeling loved or cared for 
o Not trusting others; avoiding being too close, touching or too 
connected with others 
o Never feeling good enough, having to “earn” love from parents, 
feeling criticized much of the time 
o Learning to be anxious, worried, or insecure 
	  	  
 
6. Experiential Component (30 minutes) 
• Applaud participants for recognizing conflict: Thank you for sharing those 
experiences with me, that was brave of you. The way these conflicts show up is 
normally in what you say and do with others in your life  
	  
Rationale	  
• Rationale of two core domains: autonomy (independence, assertiveness, power) and 
communion (love, connecting, trust): We all have two core needs. First, to be loved, 
accepted and cared for; to be able to trust and connect to someone. Second, we have a 
need to be independent, strong, even powerful; to take care of and protect ourselves.   
These two needs show up in our important relationships.  
• Ideally, people should be free to express both needs, but what usually happens it is hard, 
at least in some relationships.  
	  
SYMPTOMS:	  How	  would	  you	  rate	  your	  physical	  symptoms	  right	  now,	  on	  a	  scale	  from	  0-­‐
10;	  0(no	  pain),	  10(worst	  pain).	  	  
	  
General	  Demonstration	  	  
• I want to see what it is like for you to express both of those sides of yourself. 
• Show me what it would look like to use voice, tone and body to engage in assertiveness 
and being powerful, and the other side of caring, connection, and love. 
 
 Domain	  I:	  Communion	  	  	  
Q: How can you express sadness, or love, or longing for someone? 
 
o What words or sayings can you share that help bring you closer to another person, to 
connect with them?   
• I’m sorry about what I did to you. 
• I don’t want to lose you. 
• I want to be close to you. 
• I love you. 
• Thank you for doing that for me. 
• I was wrong.  (You were right.) 
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• I don’t want to hurt you. 
• I want you and me to have a closer, more genuine relationship. 
• You really are important to me. 
 
Q: What tone do you have in your voice?   
 
o It should be connecting, genuine, soft 
 
Q: What posture do you show with your body?  Your face? 
 
o Demonstrate such postures…open body and arms…face soft 	  	  Domain	  II:	  Agency	   	  	  
Q:	  	  What	  are	  some	  words	  that	  we	  use	  when	  we	  mean	  that	  we	  are	  angry?	  	  
o Generate	  list	  of	  words	  ranging	  “intensity”	  from	  very	  low	  (e.g.,	  annoyed)	  to	  very	  high	  (enraged,	  furious)	  	  	  
Q:	  What	  posture	  can	  you	  use	  to	  show	  anger	  or	  strength?	  	  	  
o Standing	  tall,	  proud,	  arms	  crossed	  
o Standing	  akimbo	  (hands	  on	  hips/	  defensive	  posture)	  
o Pointing	  at	  someone	  exercise	  
o Strong	  /	  angry	  gestures	  (e.g.,	  flipping	  the	  bird,	  thumbing	  the	  nose,	  etc.)	  	  
• Close your eyes and imagine someone trying to hurt your body….or take your 
children….or touch you in a way that you don’t want.   
o What does your body want to do? Your hands? 
o Picture yourself pushing that person very hard, Punching that person, Choking 
that person 	  
• How about facial expressions of anger? What do they look like?   
 
• Note: You cannot smile and be angry: smiling is usually a barrier or defense 
• How about tears instead of anger?  Usually they are learned ways to reduce your 
anger and avoid hurting someone. 
 
Q: How can your voice show anger?  
 
o Voice loudness: Many people have trouble yelling …help them do it, escalating 
the volume and intensity 
§ Try “NO!” and increase in volume and intensity 
§ Try “I WILL NOT” and do the same thing.   
§ Try: I AM MAD AT YOU! 
 
68	  
	  
PROMPTS:	  How	  is	  that	  for	  you?	  	  How	  hard	  or	  easy?	  
SYMPTOMS:	  How	  would	  you	  rate	  your	  physical	  symptoms	  right	  now,	  on	  a	  scale	  from	  0-­‐10;	  
0(no	  pain),	  10(worst	  pain).	  	  
 
 
Specific	  Demonstrations,	  ASK:	  	  Rationale:	  	  	  
• Stress is very often having these two needs conflict with each other, or be suppressed.  
Stress is often being trapped when you have these important things to be expressed, but 
you feel stuck—that it is wrong or dangerous to express them. 
 
• You are doing these things in this private meeting, this doesn’t mean that we are 
encouraging you to do them in their relationships.  But that the goal here is to have you 
“try on” new ways of expressing yourself 	  
• Then, how does this apply to key people in your life?  
• Show me what it looks like to be X, Y with person Z 
• Is there a part of you what would like to express X and Y to Z 
• I’d like to do a test run of how you can express some of these important emotions  
• Take them through expressing their emotions to one or two important people who they 
have conflict with 
• Identify a conflicted relationship from the person’s stress interview. 
	  
	  
PROMPTS:	  How	  is	  that	  for	  you?	  	  How	  hard	  or	  easy?	  
SYMPTOMS:	  How	  would	  you	  rate	  your	  physical	  symptoms	  right	  now,	  on	  a	  scale	  from	  0-­‐10;	  
0(no	  pain),	  10(worst	  pain).	  	  	  
7. Wrap up: (10 minutes) 
• What have you discovered about yourself? Your symptoms? The connections? 
• How did you feel about the interview? What were your reactions? Likes/dislikes? 
• Give them feedback, offer it as a hypothesis: This is an area of strength, this is an 
area of strength..etc, Seems like expression of anger is anxiety provoking for you, 
that’s pretty common, may be beneficial for you to work on it and get more 
comfortable about 
• For	  many	  people,	  the	  stress	  of	  keeping	  things	  suppressed	  actually	  contributes	  to	  their	  physical	  
symptoms,	  and	  that	  relief	  from	  symptoms	  happens	  when	  they	  are	  able	  to	  express	  their	  genuine	  
feelings.	  This	  can	  be	  done	  in	  writing,	  privately	  when	  you	  are	  alone,	  and	  even	  directly	  to	  a	  person,	  
though	  when	  you	  do	  that,	  you	  usually	  need	  to	  communicate	  more	  gently,	  both	  of	  your	  needs	  (love	  
and	  power)	  	  
 
8. Complete “Post-Session Ratings” 
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APPENDIX C. POST-SESSION HANDOUT  
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APPENDIX D. CONSENT FORM  
 
HIC # 2014-151 
Version # 3/10/14 
IRB NUMBER: 2014--151 
IRB APPROVAL DATE: 08/01/2014 
IRB EXPIRATION DATE: 07/31/2015!
CONSENT FORM AND AUTHORIZATION FOR DISCLOSURE OF PROTECTED 
HEALTH INFORMATION 
 
STUDY TITLE: LIFE-STRESS INTERVIEW FOR WOMEN WITH CHRONIC 
UROGENITAL PAIN  
 
Principal Investigator: Jennifer Carty, M.A.  
Address: 3601 West 13 Mile Rd., 2 South, Royal Oak, MI 48073 
 
Hospital: William Beaumont Hospital  
 
INTRODUCTION 
Why is this study being done? 
You are being asked to participate in a clinical research study. The purpose of clinical research is 
to look at the nature of disease and try to develop improved methods to diagnose and treat 
disease. The researcher in charge of the study believes you meet the initial requirements to take 
part in the study. Before agreeing to participate, it is important for you to read and understand the 
following explanation of the research procedures. This consent and authorization form describes 
the purpose, procedures, benefits, risks and discomforts of the study. It also describes the 
alternatives available to you, and your right to withdraw (quit) from the study at any time.  
 
Please read this information carefully and ask as many questions as you like before deciding 
whether or not you would like to take part in this research study.  
 
The goal of this study is to have women with chronic urogenital pain participate in a life-stress 
interview that will ask about your health history, stressful life experiences, and how stressful life 
experiences have effected your health, if at all. This study will also examine if participating in 
this type of life-stress interview can improve your physical and mental health.  
 
A total of 150 women will take part in this study being done at William Beaumont Hospital.  
 
How long will I be in the study? 
If you decide to take part in this study, your participation is expected to last 6 to 8 weeks.  
 
DESCRIPTION OF THE STUDY 
What will happen if I take part in the research study? 
If you choose to be a participant in the study, you will be assessed, during your first visit, to 
determine if you qualify to participate. After signing this Consent and Authorization, you will 
have a 1-hour “baseline” evaluation session during which you will fill out questionnaires on a 
computer at home about your physical symptoms, mood, functioning, and attitudes about your 
health and treatment. Six weeks after the start of the study, you will be asked to complete a 
“follow-up evaluation” where you will complete the same questionnaires as you did at the 
baseline evaluation. 
 
After the baseline evaluation session, you will be randomly assigned (like picking numbers out 
of a hat) to one of two groups. You have a 2 out of 3 chance of being assigned to the Immediate 
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Interview group in which you will be interviewed as soon as possible, and you have a 1 out of 3 
chance of being assigned to the Delayed Interview group, where you will be interviewed after the 
follow-up evaluation (about 6 weeks after starting the study).   
 
The interview that you will have will last about 1 and a half hours (90 minutes). During the 
interview, you will meet privately with a therapist, who will review your health history, stressful 
events and experiences in your life, examine links between your stress and health, and examine 
how you deal with your emotions and express them. The session with the therapist will be 
audiorecorded so that the therapist can be supervised. Also, at the beginning and end of each 
session, you will be asked to rate your mood, physical symptoms, and attitudes toward the 
interview.  
 
The following activities will occur at the specific study visits: 
 
Visit 1 – Screening and study 
overview 
 
 
• Occurs in person at the Women’s Urology 
Center or via telephone 
• Assessed for study eligibility  
• Complete consent  
Visit 2 – Baseline evaluation and 
randomization 
• Occurs at home 
• Complete within 1 week of visit 1 
• Completed online or using paper forms 
• Questionnaires assessing physical symptoms, 
mood, functioning, and attitudes about your 
health and treatment 
• After measures are completed, you will be 
called to be randomized 
Visit 3 – Immediate Interview  • Occurs within 1 week after visit 2 
• Immediate Interview Group will return to the 
Women’s Urology Center for the 90-minute 
interview 
• Delayed Interview Group – no visit   
Visit 4 – Follow-up evaluation • Occurs at home 
• 6-weeks post-randomization  
• Completed online or using paper forms 
• Questionnaires assessing physical symptoms, 
mood, functioning, and attitudes about your 
health and treatment 
 
Visit 5 – Delayed Interview  • After completion of Visit 4 
• Immediate Interview Group – no visit 
• Delayed Interview Group will return to the 
Women’s Urology Center for the 90-minute 
interview !
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FDA Clinical Trial Information 
A description of this clinical trial will be available on http://www.ClinicalTrials.gov, as required 
by U.S. Law. This website will not include information that can identify you. At most, the 
website will include a summary of the results. You can search this website at any time.  
 
 
RISKS, SIDE EFFECTS AND DISCOMFORTS 
What side effects or risks can I expect from being in the study? 
 
Risks of the Life-Stress Interview: 
Less Frequent (occurring from 1% to 10% of the time) 
• Short-term emotional upset 
 
There is a rare risk of breach of confidentiality (release of information which personally 
identifies you). Although most information will be kept confidential, there are some instances 
where we are obligated to report our concerns to the authorities.  The following information must 
be released/reported to the appropriate authorities if at any time during the study there is concern 
that:  
o You are at risk for harming yourself or another person  
o Child abuse or elder abuse has possibly occurred,  
o You have a reportable communicable disease (i.e., certain sexually transmitted diseases or 
HIV) 
o You disclose illegal criminal activities, illegal substance abuse, or violence 
 
Additionally, because we are recording your name, address, and phone number there is a risk of 
a breach or loss of confidentiality. Not all possible effects are known. With any assessment 
technique, unusual, unexpected or previously unreported side effects may occur. You will be 
informed of any significant new findings, which develop during the course of this research study, 
which may change your decision to continue participating in this study. 
 
 
BENEFITS 
What are the benefits of taking part in this study? 
By taking part in this study you might learn more about stress in your life, and how stress is 
related to your physical health; however, there may be no direct benefit to you from taking part 
in this study. This might also reduce your physical symptoms or improve your mood, but this 
cannot be guaranteed. Additionally, information gained from the results of this study may be of 
benefit to others in the future, with a similar medical condition. 
 
ALTERNATIVE OPTIONS 
What are my choices other than taking part in this study? 
You do not have to take part in this study. The alternative is to decline participation. You can 
also obtain stress management interventions from practitioners in the community, and you can 
consult your physician about this. 
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ECONOMIC CONSIDERATIONS 
What are the costs of taking part in this study? 
There is no cost to you for participating in this study. You will be compensated after each 
evaluation session that you complete and for the interview. You will receive $10 for each 
evaluation session and $20 for the interview for a total of $40.  
 
COMPENSATION 
What happens if I am injured because I took part in this study? 
Your involvement in this study voluntary. The possible risks and side effects that might occur 
during the course of the research study have been described in this Consent and Authorization 
form. A research injury is any physical injury or illness caused by your participation in this 
study. 
 
Should any unintentional injury or damage result from you taking part in this study, there are no 
designated funds provided for subsequent medical care or compensation by either the study 
researchers or William Beaumont Hospital.  
 
What are my rights if I take part in this study? 
You are not giving up any of your legal rights by signing this form. 
 
CONFIDENTIALITY, DISCLOSURE AND USE OF YOUR INFORMATION 
Will my medical information be kept private? 
In order for this research study to take place, you must also authorize the researchers to access 
and use some of your protected health information (PHI). PHI is information that could identify 
you as an individual such as name, address, date of birth, etc. By signing this Consent and 
Authorization Form, you will give William Beaumont Hospital permission to use and/or disclose 
(release) your health information related to this research. Your medical and billing records 
collected for the purpose of the study will remain confidential, but may be disclosed (released) or 
used by the following and/or their representatives: 
• The investigators (principal investigator, research staff) 
• William Beaumont Hospital 
• The Food and Drug Administration  
• Other governmental regulatory agencies (domestic and/or foreign)  
• Your health insurance company and/or group health plans and their intermediaries 
(companies contracted to process claims) may also have access to your medical and 
billing records of the study. 
 
The purpose for this disclosure (release) or use is, for example, to ensure compliance with the 
study protocol, to evaluate the effectiveness of the study, and/or to provide protection to you as a 
research study participant. The disclosure and use of your information will continue after your 
involvement in the study has ended. There is no expiration date for the use of your medical and 
billing records from the study. Any information about you disclosed to the parties identified 
above may be re-disclosed by them; however, such re-disclosure is not under the protections of 
this Consent and Authorization.  
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You will not be identified in any publication, other release of study results, data, and other 
information (such as in professional writings, at professions meetings, and in the study sponsor’s 
product information, and/or advertising or other promotional materials).  
 
If you decide to withdraw your authorization for the researchers to access and use your personal 
health information before the end of the study, you may be withdrawn from the research study. 
However, where the study relied on your Consent and Authorization for the time you 
participated in the study, your Consent and Authorization cannot be withdrawn and the 
information already collected may still be used and disclosed as you previously authorized.  
 
STOPPING STUDY PARTICIPATION 
What if I decide to stop taking part in the study? 
Taking part in this research study is completely voluntary. You may choose not to take part or to 
stop being in the study (withdraw) at any time without penalty or loss of benefits to which you 
are otherwise entitled, or without jeopardizing your medical care by your clinician at William 
Beaumont Hospital. However, if you do not agree to sign this Consent and Authorization form, 
you will not be able to take part in this study.  
 
If you decide to withdraw from the study you will need to notify the principal investigator, in 
writing, of your decision to stop taking part in the study. This notice may be sent to Jennifer 
Carty, M.A., at William Beaumont Hospital, Women’s Urology Center, 2 South, 3601 West 13 
Mile Road, Royal Oak, MI 48073.  
 
Your participation in this study may be stopped by the principal investigator, without your 
consent, for any reason, which will be explained to you. Examples include: 
• The study procedures appear to be medically harmful to you. 
• You fail to follow directions for participating in the study. 
• It is discovered you do not meet the study requirements.  
• The study is cancelled. 
• It is determined to be in your best interest. 
 
CONTACTS 
Who can answer my questions about the study? 
You may talk to the principal investigator about any questions or concerns regarding your study 
participation, or if you think you may have suffered a research-related injury. The principal 
investigator in charge of the study, Jennifer Carty, M.A., may be reached at (313) 577-2304 to 
answer your questions.  
 
If you have questions regarding your rights as a research participant, or have problems, concerns, 
complaints, want information or would like to offer input, you may contact the Institutional 
Review Board (Human Investigation Committee) Chairperson at (248) 551-0662. The Human 
Investigation Committee is charged with the oversight of all human participant research 
conducted at William Beaumont Hospital facilities.  
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STATEMENT OF VOLUNTARY PARTICIPATION 
I have read the above, have asked questions and have received answers about this study to my 
satisfaction. I understand what I have read and willingly give my consent to participate in LIFE-
STRESS INTERIVEW FOR WOMEN WITH UROGENITAL PAIN AND 
GYNECOLOGIC DISORDERS. I understand I will receive a signed copy of this document 
and will be promptly informed of any new findings regarding this study. I further authorize the 
use or disclosure of my health and personal information contained in records as described above.  
 
______________________________________ 
RESEARCH PARTICIPANT NAME (PLEASE PRINT)         
 
______________________________________             _______________     _____________ 
 RESEARCH PARTICIPANT SIGNATURE    DATE   TIME 
 
ALTERNATIVE SIGNATURE (IF RESEARCH PARTICIPANT UNABLE TO SIGN) 
AS THE PERSONAL/LEGAL REPRESENTATIVE OF THE STUDY PARTICIPANT, PLEASE PRINT 
PARTICIPANTS NAME ABOVE IN THE RESEARCH PARTICIPANT SECTION, AND CHECK ONE OF THE 
BOXES BELOW AS THE BASIS FOR YOUR AUTHORITY TO SIGN THIS CONSENT AND AUTHORIZATION: 
 
 COURT-APPOINTED GUARDIAN            DURABLE POWER OF ATTORNEY                 
  NEXT OF KIN                         
*COURT LETTER IS REQUIRED           *ATTORNEY LETTER MUST BE PRESENT & VERIFIED BY 2 
PHYSICIANS 
 
__________________________________                       ________________________________ 
NAME (PLEASE PRINT)                                              RELATIONSHIP TO PARTICIPANT    
 
 
_____________________________________                     _____________           ____________ 
SIGNATURE                    DATE                          TIME 
 
 
                    WITNESS TO SIGNATURE ON CONSENT         WITNESS TO CONSENT PROCESS AND 
SIGNATURE  
 
_______________________________________ 
WITNESS NAME (PLEASE PRINT) 
 
_______________________       ________________       ____________  
WITNESS SIGNATURE                   DATE    TIME 
 
AUTHORIZED CONSENT PROVIDER STATEMENT: 
I have explained this study and have offered the study participant an opportunity for any further 
discussion or clarification. 
 
____________________________                       ____________                 _______________ 
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NAME (PLEASE PRINT)                        CREDENTIALS             PHONE 
NUMBER 
 
_________________________________                __________________          ____________ 
SIGNATURE                                                      DATE                 TIME 
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APPENDIX E. MEASURES  
Sociodemographic Form 
1. Age ____ 
 
2. Ethnicity: 
____ Hispanic/Latino  
____ Middle Eastern  
 
3. Race: 
____ African American/Black 
____ Asian 
____ Caucasian/White 
____ American Indian and Alaska Native 
____ Other  
 
4. What is the highest level in school that you completed? 
___ Less than 8th grade [record highest grade completed] 
___ Some high school [record highest grade completed] 
___ High school graduate 
___ GED 
___ Some college [record number of yrs completed if less than AA] 
___ Technical degree or AA 
___ College degree [e.g. BA/BS] 
___ Graduate or professional degree [indicate which degree MA, PhD, DO, MD)] 
 
5. What is your current relationship status? 
___ Married 
___ Separated 
___ Divorced 
___ Widowed 
___ Never married 
___ Living with a partner in a committed relationship 
 
6. What is your current employment status? 
___ Homemaker 
___ Unemployed 
___ Retired 
___ On disability 
___ On leave of absence 
___ Full-time employed 
___ Part-time employed 
___ Full-time student only 
 
7. What is your household income? 
___ Less than $10,000 
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___ $10,000 to $14,999 
___ $15,000 to $24,999 
___ $25,000 to $34.999 
___ $35,000 to $49,999 
___ $50,000 to $74,999 
___ $75,000 to $99,999 
___ $100,000 to $149.999 
___ $150,000 to $199,999 
___ $200,000 or more 
 
79	  
	  
MEDICAL INFORMATION AND HISTORY 
1. Primary diagnosis: _______________________ 
2. Onset of those symptoms: ____________ [record year] 
3. Date of First Diagnosis: ____________ [record year] 
4. Have you experienced pain or symptoms today?  ______Yes  ______No 
               In past 2 months?    ______Yes  ______No 
 
5. Is your health affected by any of the following medical problems? 
_____ Heart disease     _____Lupus 
_____ Diabetes     _____Scleroderma 
_____ Hypertension     _____ Rheumatoid Arthritis 
_____ Chronic lung disease    _____Headaches 
_____ Cancer       _____migraine? 
_____ Gout       _____ other 
_____ Stroke      _____ Irritable Bowel Syndrome  
_____ Syncope/Fainting    _____ Crohn’s Disease 
_____ Kidney disease     _____ Ulcerative Colitis 
_____ Liver disease     _____ Chronic Pelvic Pain 
_____ Ulcer or other stomach disease  _____ Interstitial Cystitis 
_____ Psychiatric illness or mental disorder  _____ Vulvodynia 
_____ Alcohol or drug use    _____ Asthma 
 
Other Medical Conditions? ________________________________________________. 
 
6. Height  (in feet and inches): _____________. Weight  (in pounds) : _____________. 
 
 
80	  
	  
ALTERNAIVE TREATMENTS INFORMATION  
 
Many people try a lot of different things to help with their health. Tell me if you have ever used 
or tried each of the following things to improve your symptoms. 
       Past    Present    No          
Eating healthier or changing your nutrition ………………….      
Eating herbal remedies ………………………………………            
Using over-the-counter or non-prescription medications …… ⁫    ⁫           
Using street drugs such as marijuana, cocaine, or others …… ⁫    ⁫            
Praying, reading the Bible, or other religious things by yourself…    ⁫         
Attending religious services (includes revival, laying on of    
hands, etc.) …………………………………………………       
Acupuncture ……………………………………………………. ⁫    ⁫           
Biofeedback ……………………………………………       
Talking with a counselor or psychotherapist ………………       
Physical therapy ………………………………………………… ⁫    ⁫    
Exercise ………………………………………………………… ⁫    ⁫    
Imagery, relaxation, or meditation ……………………………… ⁫    ⁫    
Support group …………………………………………………… ⁫    ⁫     
Magnets or copper bracelets …………………………………….    
        
        
Any other type of treatment for your symptoms? In the past         Presently 
 
Treatment     
____________________       ⁫    ⁫        
____________________       ⁫    ⁫        
____________________       ⁫    ⁫        
____________________       ⁫    ⁫
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General Symptom Interpretation Questionnaire 
     Listed below are conditions you may or may not have ever experienced. For each condition, 
please circle the letter next to each reason or group of reasons that corresponds to how much that 
might explain your condition. Please check every item for each question. Also, answer whether 
you have had the condition in the past 3 months by circling A (YES) or B (NO). Please answer 
all questions. 
     
1. If I had a prolonged headache, I would probably think that it is because: 
    I am emotionally upset A B C D 
There is something wrong with my muscles, nerves or brain A B C D 
A loud noise, bright light or something else has irritated me A B C D 
Have you had a prolonged headache in the last 3 months? A - Yes 
B - 
No 
     2. If I was sweating a lot, I would probably think that it is because: 
    I must have a fever or infection A B C D 
I’m anxious or nervous A B C D 
The room is too warm, I’m overdressed or working too hard A B C D 
Have you noticed yourself sweating a lot in the last 3 months? A - Yes 
B - 
No 
     3. If I got dizzy all of a sudden, I would probably think it is because: 
    There is something wrong with my heart or blood pressure A B C D 
I am not eating enough or I got up too quickly A B C D 
I must be under a lot of stress A B C D 
Have you felt dizzy in the last 3 months? A - Yes 
B - 
No 
     4. If I noticed my mouth was dry, I would probably think it is because: 
    I must be scared or anxious about something A B C D 
I need to drink more liquids A B C D 
There is something wrong with my salivary glands A B C D 
Have you had a dry mouth in the last 3 months? A - Yes 
B - 
No 
     5. If I felt my heart pounding in my chest, I would probably think it is 
because: 
    I’ve exerted myself or drunk a lot of coffee A B C D 
I must be really excited or afraid A B C D 
There must be something wrong with my heart A B C D 
Have you noticed your heart pounding in the last 3 months? A - Yes 
B - 
No 
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     6. If I felt fatigued, I would probably think it is because: 
    I’m emotionally exhausted or discouraged A B C D 
I’ve been over-exerting myself or not exercising enough A B C D 
I’m anemic or my blood is weak A B C D 
Have you felt fatigued in the last 3 months? A - Yes 
B - 
No 
     7. If I noticed my hand trembling, I would probably think it is because: 
    I might have some sort of neurological problem A B C D 
I’m very nervous A B C D 
I’ve tired the muscle in my hand A B C D 
Have you noticed your hands trembling in the last 3 months? A - Yes 
B - 
No 
     8. If I had trouble sleeping, I would probably think it is because: 
    Some kind of pain or physical discomfort is keeping me awake A B C D 
I’m not tired or I had too much coffee A B C D 
I’m worrying too much or I must be nervous about something A B C D 
Have you had trouble sleeping in the last 3 months? A - Yes 
B - 
No 
     9. If my stomach was upset, I would probably think it is because: 
    I’ve worried myself sick A B C D 
I have the flu or stomach irritation A B C D 
I’ve had something to eat that did not agree with me A B C D 
Have you had an upset stomach in the last 3 months? A - Yes 
B - 
No 
     10. If I lost my appetite, I would probably think it is because: 
    I’ve been eating too much or my body doesn’t need as much food as before A B C D 
I’m worrying so much that food just doesn’t taste good anymore A B C D 
I have some stomach or intestinal problem A B C D 
Have you lost your appetite in the last 3 months? A - Yes 
B - 
No 
     11. If I had a hard time catching my breath, I would probably think it is 
because: 
    My lungs are congested from infection, irritation or heart trouble A B C D 
The room is stuffy or there is too much pollution in the air A B C D 
I’m over-excited or anxious A B C D 
Have you had a hard time catching your breath in the last 3 months? A - Yes 
B - 
No 
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12. If I noticed numbness or tingling in my hands or feet, I would probably 
think it is because: 
    I’m under emotional stress A B C D 
There is something wrong with my nerves or blood circulation A B C D 
I am cold or my hand or foot went to sleep A B C D 
Have you had numbness or tingling in your hands or feet in the last 3 
months? 
A - 
Yes 
B - 
No 
     13. If I was constipated or irregular, I would probably think it is because: 
    There is not enough fruit or fiber in my diet A B C D 
Nervous tension is keeping me from being regular A B C D 
There is something wrong with my bowels or intestines A B C D 
Have you been constipated or irregular in the last 3 months? A - Yes 
B - 
No 
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Specific Symptom Interpretation Questionnaire 
     Listed below are conditions you may or may not have ever experienced. For each condition, please circle the 
letter next to each reason or group of reasons that corresponds to how much that might explain your condition. 
Please check every item for each question. Also, answer whether you have had the condition in the past 3 
months by circling A (YES) or B (NO). Please answer all questions. 	  
  
 
A B C D 
 
Not 
at 
all 
Some
-what 
Quite 
a bit 
A 
great 
deal 
    
1. If I experience elevated physical symptoms related to my 
pelvic disorder, I would probably think that it is because of:     
My biology or physical make-up A B C D 
My psychology or emotions  A B C D 
Something in my environment  A B C D 
Have you had elevated physical symptoms in the last 3 
months? A - Yes B - No 
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Change Assessment Questionnaire 
 
0 = Strongly Disagree 
1 = Disagree 
2 = Undecided 
3 = Agree 
4 = Strongly Agree 
 
 SD D U A SA 
1. The best thing I can do is find a doctor who can figure out 
how to get rid of my symptoms once and for all. 	   0 1 2 3 4 
2. Even if my symptoms doesn’t go away, I am ready to start 
changing how I deal with it. 
 
0 1 2 3 4 
3. I am testing out some stress management techniques to 
manage my symptoms better. 
 
0 1 2 3 4 
4. My symptoms are a medical problem and I should be dealing 
with physicians about it. 
 
0 1 2 3 4 
5. I realize now that it is time for me to come up with a better 
plan to cope (e.g. stress management techniques) with my 
symptoms.  
 
0 1 2 3 4 
6. I use what I have learned to help keep my symptoms under 
control.  
 
0 1 2 3 4 
7. All of this talk about how to manage stress better is a waste of 
time. 
 
0 1 2 3 4 
8. I am beginning to wonder if I need to get some help to 
develop skills for dealing with my symptoms. 
 
0 1 2 3 4 
9. I have started to come up with strategies to help myself 
control my symptoms. 
 
0 1 2 3 4 
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BRIEF	  PAIN	  INVENTORY	  	  1. Please	  rate	  your	  pain	  by	  circling	  the	  one	  number	  that	  best	  describes	  your	  pain	  at	  its	  
worst	  in	  the	  last	  week.	  	   0	  1	   2	   3	   4	   5	   6	   7	   8	   9	   10	  	  	  	  	  No	  pain	   	   	   	   	   	   	   	   	   	  	  	  	  	  Pain	  as	  bad	  as	  	   	   	   	   	   	   	   	   	   	   	  	  	  	  	  you	  can	  imagine	  2. Please	  rate	  your	  pain	  by	  circling	  the	  one	  number	  that	  best	  describes	  your	  pain	  at	  its	  
least	  in	  the	  last	  week.	  	   0	  1	   2	   3	   4	   5	   6	   7	   8	   9	   10	  	  	  	  	  No	  pain	   	   	   	   	   	   	   	   	   	  	  	  	  	  Pain	  as	  bad	  as	  	   	   	   	   	   	   	   	   	   	   	  	  	  	  	  you	  can	  imagine	  3. Please	  rate	  your	  pain	  by	  circling	  the	  one	  number	  that	  best	  describes	  your	  pain	  on	  the	  
average	  for	  the	  last	  week.	  	   0	  1	   2	   3	   4	   5	   6	   7	   8	   9	   10	  	  	  	  	  No	  pain	   	   	   	   	   	   	   	   	   	  	  	  	  	  Pain	  as	  bad	  as	  	   	   	   	   	   	   	   	   	   	   	  	  	  	  	  you	  can	  imagine	  
4. Please	  rate	  your	  pain	  by	  circling	  the	  one	  number	  that	  tell	  how	  much	  pain	  you	  have	  
right	  now.	  	   0	  1	   2	   3	   4	   5	   6	   7	   8	   9	   10	  	  	  	  	  No	  pain	   	   	   	   	   	   	   	   	   	  	  	  	  	  Pain	  as	  bad	  as	  	   	   	   	   	   	   	   	   	   	   	  	  	  	  	  you	  can	  imagine	  For	  the	  next	  set	  of	  questions,	  choose	  the	  one	  number	  that	  describes	  how,	  during	  the	  past	  week,	  pain	  has	  interfered	  with	  the	  following	  activities.	  	  Please	  use	  the	  0	  to	  10	  scale,	  where	  a	  0	  means	  that	  “pain	  does	  not	  interfere	  with	  that	  activity”	  and	  a	  10	  means	  that	  “pain	  completely	  interferes.”	  
Does	  not	  
interfere	   	  	   Completely	  interferes	  
0	   1	   2	   3	   4	   5	   6	   7	   8	   9	   10	  
	  
a)	  General	  Activity……………………………………………..….0	  	  	  1	  	  	  2	  	  	  3	  	  	  4	  	  	  5	  	  	  6	  	  	  7	  	  	  8	  	  	  9	  	  	  10	  
b)	  Mood…………………………………………………………….....0	  	  	  1	  	  	  2	  	  	  3	  	  	  4	  	  	  5	  	  	  6	  	  	  7	  	  	  8	  	  	  9	  	  	  10	  
c)	  Mobility	  (ability	  to	  get	  around)……………….…………..0	  	  	  1	  	  	  2	  	  	  3	  	  	  4	  	  	  5	  	  	  6	  	  	  7	  	  	  8	  	  	  9	  	  	  10	  
d)	  Normal	  Work	  (includes	  both	  work	  outside	  the	  home	  and	  housework)	  	  	  	  	  	  .……………………………………………………………………….0	  	  	  1	  	  	  2	  	  	  3	  	  	  4	  	  	  5	  	  	  6	  	  	  7	  	  	  8	  	  	  9	  	  	  10	  
e)	  Relations	  With	  Other	  People………………………..…….0	  	  	  1	  	  	  2	  	  	  3	  	  	  4	  	  	  5	  	  	  6	  	  	  7	  	  	  8	  	  	  9	  	  	  10	  
f)	  Sleep………………………………………………………..……….0	  	  	  1	  	  	  2	  	  	  3	  	  	  4	  	  	  5	  	  	  6	  	  	  7	  	  	  8	  	  	  9	  	  	  10	  
g)	  Enjoyment	  Of	  Life……………………………………..……….0	  	  	  1	  	  	  2	  	  	  3	  	  	  4	  	  	  5	  	  	  6	  	  	  7	  	  	  8	  	  	  9	  	  	  10	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Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2) 	  This	  questionnaire	  provides	  you	  with	  a	  list	  of	  words	  that	  describe	  some	  of	  the	  different	  qualities	  of	  pain	  and	  related	  symptoms.	  Please	  put	  an	  X	  through	  the	  numbers	  that	  best	  describe	  the	  intensity	  of	  each	  of	  the	  pain	  and	  related	  symptoms	  you	  felt	  during	  the	  past	  week.	  Use	  0	  if	  the	  word	  does	  not	  describe	  your	  pain	  or	  related	  symptoms.	  	  
1. Throbbing pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
  	   	   	   	   	   	   	   	   	   	   	   	  
2. Shooting pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
  	   	   	   	   	   	   	   	   	   	   	   	  
3. Stabbing pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
  	   	   	   	   	   	   	   	   	   	   	   	  
4. Sharp pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
  	   	   	   	   	   	   	   	   	   	   	   	  
5. Cramping pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
  	   	   	   	   	   	   	   	   	   	   	   	  
6. Gnawing pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
  	   	   	   	   	   	   	   	   	   	   	   	  
7. Hot-burning pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
  	   	   	   	   	   	   	   	   	   	   	   	  
8. Aching pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
  	   	   	   	   	   	   	   	   	   	   	   	  
9. Heavy pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
  	   	   	   	   	   	   	   	   	   	   	   	  
10. Tender none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
  	   	   	   	   	   	   	   	   	   	   	   	  
11. Splitting pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
  	   	   	   	   	   	   	   	   	   	   	   	  
12. Tiring-exhausting none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
  	   	   	   	   	   	   	   	   	   	   	   	  
13. Sickening none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
  	   	   	   	   	   	   	   	   	   	   	   	  
14. Fearful none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
  	   	   	   	   	   	   	   	   	   	   	   	  
15. Punishing-cruel none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
  	   	   	   	   	   	   	   	   	   	   	   	  
16. Electric-shock pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
  	   	   	   	   	   	   	   	   	   	   	   	  
17. Cold-freezing pain none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
  	   	   	   	   	   	   	   	   	   	   	   	  
18. Piercing none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
  	   	   	   	   	   	   	   	   	   	   	   	  
19. Pain caused by 
light touch 
none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
  	   	   	   	   	   	   	   	   	   	   	   	  
20. Itching none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
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21. Tingling or ‘pins 
and needles’ 
none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
  	   	   	   	   	   	   	   	   	   	   	   	  
22. Numbness none 0 1 2 3 4 5 6 7 8 9 10 worst possible 
  	   	   	   	   	   	   	   	   	   	   	   	  
SF-MPQ-2 © R. Melzack and the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials 
(IMMPACT), 2009. All Rights Reserved. 
Information regarding permission to reproduce the SF-MPQ-2 can be obtained at www.immpact.org. 
 
  
89	  
	  
 
  
90	  
	  
BRIEF SYMPTOM INVENTORY 
 
Below is a list of problems and complaints that people sometimes have.  Please circle the response that 
best describes how much discomfort that problem has caused you during the past 7 days INCLUDING 
TODAY.  Please do not skip any items. 
 
       Not at all    A little bit      Moderately     Quite a bit     Extremely 
 
1.  Nervousness or shakiness inside   0             1                2                3              4 
2.  Thoughts of ending your life    0             1                2                3              4 
3.  Suddenly scared for no reason                          0             1                2                3              4 
4.  Feeling lonely     0             1                2                3              4 
5.  Feeling blue     0             1                2                3              4 
6.  Feeling no interest in things    0             1                2                3              4 
7.  Feeling fearful     0             1                2                3              4 
8.  Your feelings being easily hurt   0             1                2                3              4 
9.  Feeling that people are unfriendly or dislike you 0             1                2                3              4  
10. Feeling inferior to others    0             1                2                3              4 
11. Feeling hopeless about the future   0             1                2                3              4 
12. Feeling tense or keyed up    0             1                2                3              4 
13. Feeling very self-conscious with others  0             1                2                3              4 
14. Spells of terror or panic    0             1                2                3              4 
15. Feeling so restless that you couldn’t sit still  0             1                2                3              4 
16. Feelings of worthlessness    0             1                2                3              4 
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Global	  Response	  Assessment	  
 
Compared to when you started the study… 
 
1. How would you rate your symptoms now? 
 
 
Markedly worse 
Moderately worse Slightly	  worse	  No	  change	  Slightly	  improved	  Moderately	  improved	  	   Markedly	  improved	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IIP-32 
People have reported having the following problems in relating to other people.  Please read the list below, and 
for each item, consider whether it has been a problem for you with respect to any significant person in your life.  
Then fill in the numbered circle that describes how distressing that problem has been.   
 It is hard for me to: 
Not at all 
 (0) 
A little 
bit 
(1) 
Moderately 
(2) 
Quite a 
bit 
(3) 
Extremely 
 (4) 
1. Say “no”  to other people      
2.  Join in on groups      
3. Keep things private from other people      
4.  Tell a person to stop bothering me      
5. Introduce myself to new people      
6.  Confront people with problems that came 
up 
     
7.  Be assertive with another person      
8.  Let other people know when I am angry      
9.  Socialize with other people      
10.  Show affection to people      
11. Get along with other people      
12. Be firm when I need to be      
13. Experience a feeling of  love for another 
person 
     
14. Be supportive of another person’s goals in 
life 
     
15. Feel close to other people      
16. Really care about other people       
17. Put somebody else’s needs before my own      
18. Feel good about another person’s happiness      
19. Ask other person to get together socially 
with me 
     
20. Be assertive without worrying about hurting 
the other person’s feelings 
     
 
The following are things that you do too much. 
21. I open up to people too much.      
22.  I am too aggressive toward other people.      
23. I try to please other people too much.      
24.  I want to be noticed too much.      
25. I try to control other people too much.      
26.  I put other people’s needs before my own too 
much. 
     
27.  I am overly generous to other people.      
28.  I manipulate other people too much to get 
what I want. 
     
29.  I tell personal things to other people too much.      
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30.  I argue with other people too much.      
31. I let other people take advantage of me too 
much. 
     
32. I am affected by another person’s misery too 
much. 
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SWLS 
 
Below are five statements with which you may agree or disagree.  Using the scale below, 
indicate your agreement with each item by placing the appropriate number on the line preceding 
that item.  Please be open and honest in your responding. 
 
1 = Strongly disagree 
2 = Disagree 
3 = Slightly disagree 
4 = Neither agree nor disagree 
5 = Slightly agree 
6 = Agree 
7 = Strongly agree 
 
____ 1. In most ways my life is close to my ideal. 
____ 2. The conditions of my life are excellent. 
____ 3. I am satisfied with my life. 
____ 4. So far, I have gotten the important things I want in life. 
____ 5. If I could live my life over, I would change almost nothing. 
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Chronic urogenital pain, pressure, and dysfunction are common, affecting nearly one in 
seven women in the U.S., who are commonly diagnosed with pelvic floor dysfunction, painful 
bladder syndrome, or interstitial cystitis. Women with these symptoms tend to have co-morbid 
anxiety and depression, relatively high rates of lifetime trauma and abuse, and conflicts or stress 
from key relationships. There is theory and evidence indicating that unresolved abuse or 
emotional conflicts can trigger or exacerbate urogenital pain and other symptoms (Abbass, 2009), 
but assessment of the presence and role of psychological stress is rarely done in women’s health 
care settings. When mental health is assessed, it is typically done using brief self-report measures, 
which do not provide a comprehensive view of stress, emotions, and health, motivate patients to 
change, or relieve their symptoms. There is little research on procedures for assessing stress, 
emotional processes, and their effect on physical symptoms in medical settings. We created a 
comprehensive life-stress interview that focuses on increasing awareness of the links between 
stress, emotions, psychological conflicts and physical health through use of experiential 
techniques. We hypothesized that engaging in life-stress interview would increase awareness and 
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motivation to change view of mind-body links and reduce physical and psychological symptoms. 
Participants were 62 women with chronic urogenital pain conditions recruited from a tertiary 
care clinic for women’s urology. Participants were randomized to either the life-stress interview 
group or to a wait-list control group. Participants completed measures of physical health (BPI, 
PFDI-20-SF, PHQ-15, and GRA), psychological health (BSI and SWLS), and interpersonal 
difficulties (IIP-32) at baseline and 6-week follow-up. The life-stress interview was a one-
session, 90-minute interview conducted by a trained interviewer.  
ANCOVA analyses, controlling for depression, were conducted to determine the effects 
of the life-stress interview compared to a wait-list control group. Findings from this study 
suggest that a life-stress interview can be effective in improving health, specifically pain severity 
and pelvic floor symptom distress. Participants in the interview group showed increases in 
interpersonal domineering/control and decreases in vindictive/self-centeredness and social 
inhibition, suggesting the interview was effective in improving assertive, active engagement in 
interpersonal relationships, allowing for health balanced emotional expression and increased 
comfort in relationships. However, no effects were found on psychological health and only 
minimal effects were found on mind-body awareness. Participants in the interview group were 
less likely to attribute their pelvic symptoms to environmental causes and decreases in 
precontemplation of change, suggesting minimal shifts in mind-body awareness. In general, it 
appears that this novel, emotion-focused interview can be effective in improving health for 
women with chronic urogenital pain within tertiary care clinics for women’s health. Further, this 
study suggests that for this complex patient group emotion-focused interviews can be a useful 
alternative to cognitive-behavioral interviews.  
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